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Knowledge is of two kinds. We know a subject ourselves, or we know where we 
can find information upon it. 
(Johnson) 
 
The categories of human thought are never fixed in any one definite form; they 
are made, unmade and remade incessantly: they change with places and times. 
(Durkheim) 
Whatever is known has always seemed systematic, proven, applicable and 
evident to the knower. Every alien system of knowledge has likewise seemed 
contradictory, unproven, inapplicable, fanciful or mystical.  
(Fleck)  
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1 Introduction and questions 
 
There is animmense variety of fungi that grow on almost every kind of 
nourishment depending on climate distinctions. The infection of cereal and 
maize products with mycotoxins produces by fungicauses agricultural problems 
worldwide. Additional, it influences livestock and in a following step the health of 
humans. Mycotoxins are thermally stable and persists normally in processed 
food products. So as a fact it comes to mycotoxicoses. The total impact of these 
naturally occurring contaminants on human health cannot be estimated, due to 
insufficient toxicological information even for the most well documented toxins. 
The tolerable daily intake established by international working groups remains 
temporary or provisional [THUVANDER A. et al, 2001]. 
In relation to food and animal feed, next to aflatoxin B1 and M1,deoxynivalenol, 
fumonisins and ochratoxin A, zearalenone is one of the most important 
mycotoxins. However wheat, oats, as well as soybean products have been 
found to be contaminated occasionally with zearalenone, valid data in Europe 
indicate that maize is the most prominent cereal of high levels of contamination 
with zearalenone [EC, 2004]. Depending on climate, harvest, and storage 
conditions, maize and maize products show levels of zearalenone between 1 
and 2900 µg/kg [KUIPER-GOODMAN T.; et al., 1987]. 
The presence of ochratoxin A in human blood has been reported for many 
countries.Levels greater than 0.1 µg/kg in more than 90 % of human and swine 
blood samplesin Europe have been detected[PETZINGER E.; WEIDENBACH 
A. 2002]. The toxin exposure is based on the ingestion of contaminated food 
and animal feed and the ochratoxin Acontamination of cereal is most prominent, 
even though contaminations are influenced by storage conditions post harvest. 
Products from animals can contribute to the ochratoxin A intake of humans. 
Especially pig is known to be sensitive to the toxin, with a tissue distribution 
following the pattern kidney > liver> muscle > fat [CHIAVARO E. et al. 2002]. 
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 In the past years a few studies have been carried out on the occurrence of 
Ochratoxin A in pork and sausages [JØRGENSEN K. 1998, GAREIS M. and 
SCHEUER R. 2000], but only limited data is available on the presence of 
ochratoxin A in ham.Information about zearalenone in processed products from 
pig israre. Ochratoxin A carryover from feed to meat has been shown 
experimentally [MADSEN et al. 1982]. The kidney is highly contaminated 
followed by liver, muscle and fat. Former studies found ochratoxin A levels of 
4.6 and 3.2 µg/kg in blood- and liver type sausages. Humans may not be free of 
toxins because they are ingested with almost every meal. Research on the 
occurrence of mycotoxins and toxic fungi in Austria started in the mid 
seventies[ÖHLINGER R. et al. 2004]. 
A number of Aspergillus and Penicillium species producing ochratoxin A and 
growing on cereals and other plant substrates. It is very toxic to several animal 
species, in which the kidney being the main affected organ. Ochratoxin A 
inhibits protein synthesis [GAUTIER J.C. et al., 2001]. These mechanisms may 
generate neurotoxic, nephrotoxic and immunotoxic effects [MUNOZ et al. 2006]. 
The immune system appears to be the most sensitive among other sensitive 
organs and can be affected by very low concentrations of ochratoxin A in the 
ng/ml range. 
Zearalenone and metabolites act as estrogens and can lead to 
hyperestrogenism and severe reproductive and infertility problems in swine 
[ROSENBERG E. et al 1998]. Zearalenone biotransforms in animals in two 
metabolites α-zearalenol and β-zearalenol.Furthermore, Zearalenone showed 
to be haematotoxic, hepatotoxic, immunotoxic and genotoxic, though the exact 
mechanism of Zearalenone toxicity is not completely established [ZINEDINE A. 
et al. 2007]. From bioassays a carcinogenic activity of zearalenone has been 
indicated. Furthermore the upcoming of public awareness of substances that 
mimic or interfere with the activity of natural hormones like zearalenone give 
cause to greater study of mycotoxins with estrogenic potential. 
In conclusion, the exposure to zearalenone, α-zearalenol, β-zearalenol and 
ochratoxin A in Austria did not give rise to any major health concerns, but the 
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intake of several mycotoxins through the food chain emphasizes the need for 
preventive measures and improved control of toxin levels in further food items. 
Through the wide field of fungus kingdom and thereby emerging mycotoxins 
some efforts have already been started to develop multi-mycotoxin-detection for 
prospective food analyses (in Austria, IFA Tulln (Krska), CC Cluster Chemie 
Linz AGES GmbH (W. Brodacz)). This is quite a young field of research which 
is important to continue, to detect faster and more efficiently the presence for 
example of zearalenone, α-zearalenol, β-zearalenol, ochratoxin A and further 
mycotoxins in the food chain. Through globalization and open trade markets a 
peck of different mycotoxins in human nutrition will influence human health and 
measurements should be enforced to keep down contaminated food to lowest 
levels. 
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Questions: 
 The aim of this study is to assess zearalenone, α-zearalenol, β-
zearalenol and Ochratoxin A concentrations in processed food 
products from pigs in Austria. 
 
 Show the differences between field fungi (zearalenone) and storage 
fungi (ochratoxin A) and their effects in agriculture and livestock. 
 
 Effects of zearalenone, α-zearalenol, β-zearalenol and ochratoxin A 
exposure to human health 
 
 Novel strategies on mycotoxin prevention 
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2 Review 
 
2.1 Mycotoxins 
 
2.1.1 Historical background 
 
Mycotoxins are small (MW ~700 Dalton) toxic compounds that are formed as 
secondary metabolites by fungal species. These fungal species can colonies 
crops and contaminate them with toxins in the field or post harvest [TURNER et 
al., 2009]. Mycotoxins are capable of having acute toxic, mutagenic, 
carcinogenic, teratogenic, immunotoxic and oestrogenic effects in human and 
animals. Syndromes resulting from intake of mycotoxins by humans and 
animals are known as “mycotoxicoses”[VAN EGMOND et al., 2007]. 
Chinese used ergot alkaloids from fungi as medicinal preparations over 500 
years ago where at the Middle Ages in Europe St. Antony’s Fire was mentioned 
after human consumption of ergot contaminated grain. During the late 19th and 
early 20th century the ability of fungi to carry out fermentations for food 
preparation were recognized. This development led to the interest in the toxicity 
of these products [RICHARD 2007], but the true chemical nature of the 
secondary metabolites from fungal was not known until recent times. 
In 1922, the systematic study of fungal secondary metabolites began under the 
leadership of Harold Raistrick. He characterized more than 200 mould 
metabolites. Diseases like Alimentary Toxic Aleukia, caused by T-2 toxins from 
Fusarium sporotrichioidesgrowing on harvested cerealsin Russia during the 
Second World War[RICHARD 2003] or similar diseases occurring in the USA in 
the 1960s, led scientists began a systemic approach to the study of 
mycotoxicoses. [RICHARD 2007]. 
In 1960, the sudden appearance of turkey-X disease that resulted in the death 
of more than 100.000 turkeys in the United Kingdom led to the discovery of 
aflatoxins [BLOUNT 1961]. At that time, mycotoxins were considered as a 
storage phenomenonbecausecereals become moldy during storage. These 
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secondary metabolites were proven to be toxic to humans and animals. Later 
on, aflatoxins and other mycotoxins were found to be formed also during 
development of crop plants in the field[RICHARD 2007]. 
Regulations gradually developed for mycotoxin in food and feed, since the 
discovery of the aflatoxins in 1960. They were established by industrialized 
countries.These limits often had an advisory or guideline character [VAN 
EGMOND et al.,2007]. Due to the fact that human food could be contaminated 
with mycotoxins led to more research efforts into all areas of 
mycotoxicology.Especially into their implications for human health and therefore 
analytical methods for the chemical determination of these new identified 
compounds [SHEPHARD 2008]. 
Moreover the mycotoxin problem became a multidisciplinary issue. Analytical 
chemists, microbiologist, agronomists, agricultural engineers, entomologists, 
plant pathologists, crop breeders, geneticists, medical and veterinary 
practitioners and producerswere involved.Among the mycotoxins of severe 
health concerns are the aflatoxins, deoxynivalenol, fumonisins, zearalenone, T-
2 toxin, ochratoxins and certain ergot alkaloids. [RICHARD 2007].Therefore was 
a need for specialist laboratories due to the variety of structures of these toxins. 
For high sensitive analyses it was impossible to use one standard technique 
and these new settings created challenges for routine analysis.Until now, there 
have been several developments in detection of mycotoxins. Particular, the 
application of mass spectrometry in conjunction with for example HPLC for 
decreasing limits of detection has been of interest in recent times. Future trends 
would focus on rapid assays andtools for multiple toxin measurements from a 
single matrix[TURNER et al., 2009]. 
Due to the fact that mycotoxins pass through the food chain and are perilous for 
humans and animals governments had to focus on this problem. Through 
theincrease of the exchange of goods across national borders, and the lowering 
of trade barriers, governing bodies had todevelop regulations to ensure 
competitive trade of domestic food [KENDRA and DYER 2007].To protect the 
consumer from the harmful effects of these compounds, regulations 
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formycotoxins have been established in many countries. Until the late 90th 
mycotoxin regulations were mostly a national affair. Step by step, several 
economic communities (e.g. EU, MERCOSUR, Australia and New Zealand) 
harmonized their mycotoxin regulations.Thereby they overruled existing national 
regulations [VAN EGMOND et al., 2007]. 
Nowadays more than 100 countries have assumed regulation to limit the 
exposure of consumers to the adverse health risks from selected 
mycotoxins[FAO 2004].In 2003, the Council for Agricultural Science and 
Technology Report on mycotoxin listed the development of uniform standards 
and regulations for mycotoxin contamination in food and feed as one of the 
public policy goals for the 21st century [CAST 2003]. The regulations contain 
limits for aflatoxins (B1, B2, G1, and G2), aflatoxin M1, trichothecenes 
(deoxynivalenol, diacetoxyscirpenol, T-2 toxin and HT-2 toxin), fumonisins (B1, 
B2, and B3), agaric acid, ergot alkaloids, ochratoxin A, patulin, phomopsins, 
sterigmatocystin and zearalenone [VAN EGMOND et al., 2007]. 
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2.1.2 Field fungi vs. Storage fungi – Two different problems 
 
2.1.2.1 Field fungi - zearalenone 
 
The following focuses on two mycotoxins. The first mycotoxin zearalenone 
belongs to the family of Fusarium spp. toxins. Most zearalenone is found in 
maize, but also found in other crops such as wheat, sorghum, barley, and rye 
throughout various countries of the world [CAST, 2003]. Generally, Fusarium 
species grow at moist and cool conditions.In wheat, sorghum and maize, 
zearalenone occurs in preharvest cereals but there is not enough information 
about the occurrence of zearalenone post-harvest [WHO 2000].Theappearance 
of zearalenone occurdifferent year by year, in variably cereal cropsas well as 
geographical areas [RICHARD 2007]. Austria fits to the preferred climate 
conditions of Fusarium spp. Referring to that recent survey on the Austrian 
mycotoxin situation showed that B-trichothecene, deoxynivalenol and 
zearalenone are the most important mycotoxins occur in Austria due to a field 
fungi problem [ÖHLINGER et al., 2004]. As a matter of fact feed for pigs contain 
mostly maize and other cereals. Moreover swine is the most significantly 
affected species and is more sensitive to zearalenone than, for example, 
rodents, cattle and poultry. The most considerable effect of zearalenone is that 
it causes estrogenic effects like precocious development of mammae in young 
gilts as well as prepucial enlargement in young barrows [RICHARD 2007]. 
The “journey” of zearalenone through the food chain starts here on the field and 
progresses by the biotransformation for zearalenone in animals due to the 
formation of two metabolites α-zearalenol and β-zearalenol [ZINEDINE et al., 
2007]. The Austrian Agency of Health and Food Safety reported in their 
assessment form 2008 that the content of zearalenone and its metabolites 
could be determined in urine and liver from swine [AGES 2008]. Determined 
values of the metabolites α-zearalenol and β-zearalenol could also refer to 
illegal use of growth promoters (Zeranol; RalgroR).As zearalenone is 
accumulating in livestock, mycotoxins can reach humans through the food 
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chain.Depending on absorbed concentrations of this toxin, effects on humans 
were already noticed. 
 
2.1.2.2 Storage Fungi – Ochratoxin A 
 
The second mycotoxin mentioned in this thesis is ochratoxin A. Ochratoxin 
Aconcentrations have been found in foods of plant origin, in eatable animal 
tissues, as well as in human blood sera and tissues [KUIPER-GOODMAN and 
SCOTT 1989]. Ochratoxin Ais produced by several species of Aspergillus and 
Penicillium [PITT 2000]. But in contrast to the Fusarium toxins that grow well 
under Austrian climate conditions,as reported in the former studies, ochratoxin 
A is a mainly “imported” mycotoxin in Austria [ÖHLINGER et al., 2004]. 
Therefore it shows that mycotoxin contamination is not a national problem. To 
underline this, a study from Wu, 2004 indicates that “the United States, China 
and Argentina export more than 89% of the world’s corn.”[WU 2004].Under 
several effects of ochratoxin A mentioned above the most acute toxicity is in the 
kidney [SIMON 1996]. Furthermore it was tested that ochratoxin A elimination is 
slower in humans than in all other species[STØRMER 1992].Ochratoxin 
contamination is widespread in humans. Most people have detectable 
concentrations of ochratoxin A in their bloodstream, though usually at very low 
levels.It is imaginable that an amount of these levels is coming by nutrition 
[BAYMAN and BAKER 2006].  
 
2.1.3 How to deal with mycotoxin contamination 
 
To keep down related hazards, governments and scientists work together and 
try to find different strategies. On the one hand analytical chemists try to 
determine very low concentrations down to ppb and even ppt levels and 
develop more and more methods. Practical methods for high-sensitivity analysis 
and specialist laboratory settingsare a need for routine analysis 
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[TURNER2009]. Therefore itincludesadequate HPLC methods with UV or 
fluorometric detection. These are already used in both, research and legal 
enforcement of food safety legislation and for regulations in international 
agricultural trade. Other chromatographic methods employed for the 
determination of mycotoxins are Thin Layer Chromatography and Gas 
Chromatography.Furthermore LC-MS methods show new possibilitiesof 
analytical instruments, especially for multi toxin determination and for 
confirmation purposes [SHEPHARD 2008]. Most of these methods are 
expensive and time consuming, but for routine and rapid analysis 
immunological principles methods, like ELISA or Immunoaffinity 
Chromatography, have been developed and commercialized.On the other hand 
current discussions about mycotoxins and agricultural biotechnology reveal 
differences in risks and benefits. When faced with uncertainty, regulators willing 
do set limits as low as possible. 
 
2.1.4 Zearalenone and its metabolites 
 
2.1.4.1 Zearalenone 
 
The discovery of estrogenic mycotoxins from the study of estrogenism was first 
reported by Buxton in 1927 where swelling and eversion of the vagina in young 
gilts were observed [BUXTON1927]. The major active toxin was named 
zearalenone by Urry et al. [URRY et al., 1966] who determined the structure in 
1966 [KRSKA R. and JOSEPHS R. 2001].Besides estrogenic, alsohepatotoxic, 
haematotoxic, immunotoxic and genotoxic effects of zearalenone has been 
shown [ZINEDINE et al., 2007]. 
 
Zearalenone(C18H22O5) [6-(10-hydrox-6-oxo-trans-1-undecenyl)-β-resorcyclic-
acid-lactone]),previously known as F-2 toxin, is a nonsteroidal oestrogenic 
mycotoxin. It is biosynthesized through a polyketide pathway by Fusarium fungi, 
including F. graminearum (Gibberella zeae), F. culmorum, F. cerealis, F. 
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equiseti, F. crookwellense and F. semitectum. They are common soil fungi and 
are regular contaminants of several cereals worldwide [BENNETT and KLICH 
2003].  
Zearalenone (318.36428 g/mol) is a white crystalline compound, which exhibits 
blue-green fluorescence when excited by long wavelength UV light (360 nm) 
and a more intense green fluorescence when excited with short wavelength UV 
light (260 nm). Solubility in water is about 0.002g/100ml. It is slightly soluble in 
hexane as well as benzene, acetonitrile, methylene chloride, methanol, ethanol 
and acetone [EMAN 2010]. 
2.1.4.2 α-zearalenol 
 
α-zearalenol is a metabolite from zearalenone and can also be produced by 
Fusarium spp. Molecular formula is C18H24O5 [2,4-dihydroxy-6-[6α,10- 
dihydroxy-trans-1-undecenyl]benzoic acid micro-lactone] and molecular weight 
320.38016 g/mol. 
2.1.4.3 β-zearalenol 
 
β-zearalenol is a metabolite from zearalenone and can also be produced by 
Fusarium spp. Molecular formula is C18H24O5 [2,4-dihydroxy-6-[6β,10-
dihydroxy-trans-1-undecenyl]benzoic acid micro-lactone] and molecular weight 
is 320.38016 g/mol. 
2.1.4.4 α-zearalanol (zeranol) 
 
α-zearalanol (zeranol) (C18H26O5, 322.39604 g/mol, melting point:178-185°C) is 
a metabolite of zearalenone as well as a non-steroidal oestrogenic growth 
promoter which increases live weight gain in food animals. It has been banned 
within the EU [COUNCIL DIRECTIVE 96/23/EEC, 1996]and Member States are 
prescribed to monitor foodproducing animals for possible abuse [COUNCIL 
DIRECTIVE 1996]. 
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In the USA, zeranol has been widely adopted as a growth stimulant to improve 
fattening rates of cattle since 1969 [COUNCIL DIRECTIVE 1985] 
2.1.4.4.1 Zeranol as growth promoter in livestock 
 
It also has to be mentioned that due to the fact that food safety authorities 
investigate zeranol as a growth promoter in livestock an epidemiological study 
from Launay F. M. et al. 2004 show that zeranol is not a preferred growth 
stimulant.It describes data from involving four European Union control 
laboratories in which 8008 urine samples from bovine, porcine and caprine 
origin were screened for the presence of zeranol. Of these samples, 93.6% 
screened negative for zeranol and only 4 samples could be confirmed as true-
positive. In this study it is also mentioned that it is currently impossible to 
determine whether the presence of zeranol (and/or taleranol) have its source 
from abuse or from environmental contamination. Zeranol is generally not the 
anabolic agent of choice for farmers to promote the growth of their animals. 
Drugs like β-agonists are much more effective growth promoters and have been 
much more widely abused in the EU and elsewhere [LAUNAY et al., 2004]. 
 
2.1.4.5 β-zearalanol (taleranol) 
 
β-zearalanol, also named taleranol, is a mycotoxin and likewise a metabolite of 
zeranol. Molecular formula is C18H24O5 [3,4,5,6,7,8,9,10,11,12-decahydro-
7b,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1-one] and 
molecular weight is 322,39604 g/mol. 
 
Source: ZINEDINE A. et 
al., 2007 
Fig.1 Chemical 
structures of 
Zearalenone and its 
derivatives: (a) 
zearalenone, (b) α-
zearalenol, (c) β-
zearalenol, (d) 
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zearalanone, (e) α-zearalanol and (f) β-zearalanol  
 
 
14 
 
2.1.5 Ochratoxin A 
 
First isolation of ochratoxin A was from Aspergillus ochraceus in South Africain 
1965 [VAN DER MERWE et al., 1965]. This fungal secondary metabolitecan be 
produced by Aspergillius ochraceus, Aspergillus niger,Aspergillus carbonarius, 
Penicillium verrucosum, etc., which are known as “storage” fungi 
[BLUMENTHAL 2004]. 
 
Source: http://www.schimmel-schimmelpilze.de/images/aspergillus-rem-1000.jpg; Date: 6.12.2010 
Fig.2 Aspergillus sp.; scanning electron microscope – Magnification 1000 Times 
Ochratoxin A (C20H18ClNO6, molecular weight: 403.82 g/mol) is a colorless, 
crystalline compound and its chemical name is L-phenylalanine N-[5-chloro-3,4-
dihydro-8-hydroxy-3-methyl-1-oxo-1H2-benzopyran-7yl]carbonyl-(R)-
isocoumarin [KOS and KRSKA, 2010]. The sodium salt is soluble in water. As 
the acid, it is moderately soluble in polar organic solvents like chloroform, 
methanol and acetonitrile and dissolves in dilute aqueous sodium 
bicarbonate.Ochratoxins consists of an isocoumarin and a phenylalanine 
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partlinked by an amide bond.The melting point is at 168°C. [STØRMER 
1992].Ochratoxin A is chlorinated, which is unusual for natural products. 
The ultraviolet absorption spectrum, which varies with pH and solvent polarity, 
shows maxima at 213 nm and 332 nm in ethanol. A maximum in the 
fluorescence emission spectrum can be observed at 428 nm[KOS and KRSKA 
2010].The extinction coefficient in methanol and ethanol at 332 nm is in 
between 5500 and 6640 M-1 cm-1 [VALENTA 1998].  
 
2.1.6 Mycotoxins in agriculture by using the example of maize 
 
As we know now, a wide range of mycotoxins start their “journey” through the 
food chain by growth of crops all over the world. Placinta et al.stated: “It is 
possible that from a global perspective, Fusarium mycotoxins may be spread 
from one country to another with the increase in global grain trade.”[PLACINTA 
et al., 1999]. 
Although zearalenone is more a field mycotoxin than a storage toxin some 
reports show that high levels of zearalenone occurring naturally in some 
samples of maize based feedstuff. This could result from improper storage 
rather than development in the field [KUIPER-GOODMAN et al., 1987]. 
Additional forochratoxin A itis directly influenced by storage conditions after 
harvest.Especially in times of globalization, it means that preventing strategies 
against mycotoxin contaminationsuch as storage, transport, and processing 
conditions for cereal crops are very important. Badly treated maize crops that 
contain toxins, can be transmitted from moldy feed to swine from which a 
carryover to humans has been shown [PETZINGER and WEIDENBACH 2002]. 
Plenty of ochratoxin Acontaminated food was found in Europe. About 68.6% of 
2374 food samples were examined to contain Ochratoxin A above the detection 
limit of 0.01 µg/kg [WOLFF 2000]. 
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In the mid seventies due to the occurrence of mycotoxins and toxigenic fungi in 
Austria researches started on the estrogenic mycotoxin zearalenone as a feed 
contaminant that causes non specific sterilities in cattle in the province of Upper 
Austria [LENGAUER 1977]. In the winter of 1977/78 Fusarium toxins affected 
large stretches of Southeast Austria’s maize growing areas. Massive feeding 
problems in swine caused by these toxins led to further surveys [LEW et al., 
2001]. Due to early frost in September, heavy infestation of the ears of maize 
with Fusarium graminearum occurred, resulting in high deoxynivalenol 
concentrations, up to 20 ppm, in harvested maize.The consequence was that in 
numerous farms the pigs either refused intake of the ensiled maize kernel feed 
or throw up the feedthat they had reluctantly eaten [LEW et al., 1979]. About 
20% of Austrian’s overall arable land is involved. Mycotoxin research on maize 
plant in Austria increased because of the great importance of maize for feeding 
stuff. The influence of Fusarium species and their toxins on selection of 
varieties, fertilization, time of harvest and pest infestation being the main points 
of interest. From the report from Lew et al. it is noticed that: “it can be safely 
assumed that deoxynivalenol and its derivatives as well as zearalenone, 
moniliformin, beauvericin and nivalenol are the most common toxins 
contaminating local cereals”[LEW et al., 2001]. 
 
2.1.6.1 Mycotoxins on the field 
 
Due to higher technology standards and better knowhow, storage fungi are not 
common in Middle Europe. To deal with field fungi like Fusarium spp. has more 
priority for prevention due to the fact that it is much more work to harvest less 
contaminated crops. 
InAustria,cereal crops are harvested with 16% of moisture content inthe kernels. 
Field fungi need over 20% of moisture contents to cultivate. In contrast, 
Scandinavia cereal crops are harvested between 20 – 30% moisture content. 
Afterwardstheyare dried to 18 – 20% before storage [JOHNSSON and 
PETTERSON 1990].In Austria, the cereals stay until theyare ripe and dry at the 
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field. In this last vulnerable stage, the kernels can easily infected 
byFusariumspecies. In Austria it is not common to find a corncob with massive 
Aspergillus infection.Aspergillus and Penicilliumfungi are more typical Austrian 
storage fungi. They can occur when the crops are stored after harvesting, 
because of their moisture content or when they get moist afterwards.If cereals 
are storedbelow 13% moisture content (aw - Water activity: 0.65) after harvest, 
there is no subsequent fungi proliferation. Even at aw under 0.83 there is no 
significantly fungal growth and storagemycotoxins like ochratoxin A should not 
be of any concern.[LEW 1995]. The water activity means theratio of water vapor 
pressure above the product to the water vapor pressure over pure water at a 
certain temperature. This value is an important measure respective to the 
stability of nourishment and the influence of the occurrence of micro organisms, 
who demand different free water concentrations for their development. 
 
 
 
 
 
 
 
 
 
 
Source: http://www.biologie.uni-hamburg.de/bzf/mppg/pat.htm 
Fig.3 Infection of maize ears with F. graminearum; c: uninfected plant; wt: inoculation with wild-type conidia 
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Very high toxin concentrations are found in maize on the parts of the maize cob 
where the plant anatomy produces an incubator effect. Nevertheless only a few 
maize cobs are severely affected with Fusarium, mostly with Fusarium sacchari 
var. subglutinans and Fusarium graminearum(see Tab.1 and Tab.2) [LEW 
1995]. Besides monoculture, moist weather and the cultivation of “lateripe” or 
vulnerable strains promotes pest infestations and hence Fusarium 
contamination. A study from Lew H. et al. shows that more than 80% of the 
maize cobs that were infected with Fusarium sacchari var. subglutinanswere 
damaged by the European corn borer(Ostrinia nubilalis). The caterpillar drills 
into the maize cob and benefits fungi infection, so that mould could emerge in 
the area of the borehole.Only 15% were infected with Fusarium graminearum 
after damages by the corn borer [LEW et al., 1991]. 
An additional factorcausingFusariumtoxin contamination is climate changes.In 
the last years hotter, drier summers and milder, moist winters support fungal 
cultivation.Fusarium spp.often colonizes maize during heyday and produces 
deoxynivalenol and zearalenone. The fungi grow through the maize cob and 
furthermore into the kernels. Hence the toxin concentration of the inner part 
ismany times higher as in the kernels [LEW 2001]. 
 
 Ø Deoxynivalenol (mg/kg) Ø Zearalenone (mg/kg) 
n Kernels Cobs Kernels Cobs 
12 50 185 6 140 
Source: LEW H. 2001 
Tab. 1Concentration of toxins in kernels and cobs of maize ears visibly infected with fusaria 
 
Furthermore the harvest time is a main factor for the farmer to lower the toxin 
concentration in his crops. The sooner the maize is harvested, the lesser is the 
hazard of moldy crops and mycotoxins. 
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Crop year 1996 1997 1998 
Infected cobs 
Analyzed cobs 
 
482 
343 
 
289 
228 
 
438 
316 
 
Fusarium species 
F. graminearum 
F. subglutinans 
F. avenaceum 
F. poae 
F. proliferatum 
F. equiseti 
Other Fusaruim 
spp. 
 
47 
29 
14 
2 
2 
1 
5 
 
16 
32 
23 
17 
5 
2 
7 
 
31 
33 
17 
4 
7 
2 
6 
Source based on:http://www.boku.ac.at/diebodenkultur/volltexte/band-52/heft-3/lew.pdf 
Tab. 2Frequency distribution of Fusarium species on maize ears. 
 
The three investigated growing periods 1996, 1997, 1998, show significant 
differences of the species assemblage and therefore resulting toxin values 
concerning the climate conditions (see Tab.3). 
 
 
 
 
 
20 
 
 
Source: http://www.boku.ac.at/diebodenkultur/volltexte/band-52/heft-3/lew.pdf 
Tab. 3 Diagram based on information of:Fusarium toxins in maize grain samples of the 1996, 1997, 1998 crop 
 
2.1.6.2 Fungicides usage and cultivation 
 
Detailed preventing strategies against fungi contamination on the field on 
dependent weather conditions e. g. temperatures over 18°C and rain in 
blooming period are necessary particularly for high sensitivevarieties. For this 
the usage of fungicides could not be avoided. The operational application of the 
fungicides has to be in the development at stage of the blossom. Ideal 
timeframe is about two to four days after infection by fungi. Unfortunately the 
timeframe of the blossom varies from plant to plant inside a field and the ideal 
usage of the fungicides is easy to define.  
Most fungicides eliminate the competitive flora of Fusarium species. Due to this 
missing of competitors it led to the promotion ofthe growth of Fusariumitself 
[LENGAUER 1977].At the same time,increasedfertilization, particularly high 
nitrogen doses, increase the sensitivity of maize varieties towards Fusarium 
spp.Leaves and stalks can also contain high concentrations of deoxynivalenol 
and zearalenone, because after infection for example with 
0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
1996 1997 1998
average level of positive 
samples (mg/kg) -
Deoxnivalenol
average level of positive 
samples (mg/kg) -
Zeralenone
average level of positive 
samples (mg/kg) -
Moniliformin
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Fusariumgraminearum through moist weather conditions (like in summer and 
autumn 1996 in Austria) leaves can die off after a few days and stalks get 
fragile[LEW H. 1995]. 
Maize cultivation produces more harvest residuals than any other crop. At the 
end of the vegetation period stalks are highly infected with F. graminearum (see 
Fig.4). The fungi overwinter in and on the maize residuals and there they 
develop their fruiting bodies (perithecien). At favorable weather conditions the 
asci, the sexual spore-bearing cell produced in the perithecien, could easily 
attack the ear of the crop (see Fig. 5) [MEINERT 2003]. 
 
 
 
 
 
 
 
 
 
 
 
 
Source: http://upload.wikimedia.org/wikipedia/commons/6/6a/F.graminearum.jpg 
Fig.4Fusarium graminearum 
Source: http://www.maisadour-semences.fr/maitriser-les-fusarium-gestion-du-risque-mycotoxines/en-
fusarium-mais.php?menu=introduction&page=lexique&page2=fusarium 
Fig.5The main mycotoxins are zearalenone and deoxynivalenol produced by F. graminearum 
 
The cultivation of the soil can have significantly influence on fungi exposure. In 
some areas plant residuals stay on the surface of the soil after harvesting 
instead of plowing them into the ground. This helps against water erosion near 
hillsides. Furthermore it is a method to avoid that plant protection products 
 
 
22 
 
reach the surface water.The plant residuals which remain on the surface 
provide an infection potential for the whole vegetation period. In contrast to this, 
plowing could reduce the proliferation of Fusarium spp. over winter by 
forwarded degradation of infected material in deeper bottomset beds, especially 
at preceding crops with high hazard potential like wheat and maize. 
 
The picture below showing the vicious cycle indicates that crops are infected 
with perithecien of Fusarium graminearum season by season. 
 
Source:http://www.bayercropscience.co.uk/content.output/554/556/Crop%20Centre/Cereal%20Fungicide/
Ear%20Disease%20Complex.mspx 
Fig.6Fusarium species are a component in stem base disease and this provides the spores for infection of the ears 
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2.1.6.3 Mycotoxins and storage 
 
Primarygoal of prevention strategies is to bring uncontaminated crops into 
storage facilities and try to prevent further mycotoxins development through 
appropriate storage conditions. 
In Austria massive Aspergillus contaminated maize cobs are rare. Aspergillus 
and Penicillium are typical storage fungi who ordinarily appear after harvesting 
moist crops [LEW 1995].In northern parts of Europe where crops are harvested 
by moisture content between 20 – 30% and not properly dried before storage, 
especially Penicillium verrucosum can proliferate and produce ochratoxin A. But 
also in south eastern parts of Europe ochratoxin A can occur due to improper 
storage conditions [LEW 2001]. 
On the one hand “field hygiene” is important to prevent overwinter of fungi, on 
the other hand measurements should be used to bring in clean crops in storage 
facilities. Plant residuals that are left on the surface can provide different kinds 
of diseases for further crop generations (see Fig 7). 
 
 
 
 
 
 
 
 
Source: http://www.organicfarmermagazine.org/wp-content/uploads/2010/09/P1010331.jpg 
Fig.7Crop residuals – maize 
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On the following pictures different storage possibilities are shown. 
Discriminative practices of crops like open storage or closed facilities, stored 
cobs, kernels or ground kernel,result in different amount of work and also 
hazards of mycotoxin contamination. 
 
Source: http://lh6.ggpht.com/_5oS_IghpzYw/SvVl5gee_VI/AAAAAAAAAys/Eq-nMohorjs/Biketour+KA-
ULM+%28Sep-Oct+%2709%29+016+%5B1024x768%5D.jpg 
Fig.8Open Storage facility 
 
Source: http://www.farmersguardian.com/Pictures/inline/s/i/j/Crops_grain.jpg Source:http://www.siskiyou-county-
online.com/Agriculture/IMAG018.JPG 
Fig.9Maize Storage            Fig.10 Maize Storage Facility 
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If the operating possibilities are limited, e.g. ventilation systems with more than 
65% moisture content, preservatives are required. For this purpose organic 
acids like propionic-, formic- and sorbic acid, urea and maybe sodium hydroxide 
solution can be used.Due to the fact that mycotoxins are robust compounds, 
heating is not an effective measurement. Mycotoxins remain stable and the only 
effect is that the germs content is decreased and the shelf life is improved 
[COENEN 2003]. After proper ensilage fungi cannot proliferate because of 
rapidly decreasing oxygen shortage and increasing CO2concentrations. 
Therefore no further mycotoxin production occurs, but already produced toxins 
persist. [LEW 2001] 
 
2.1.6.4 Impact of mycotoxins in feed for swine 
 
In recent years, increasing attention has been paid to the riskof chemical 
contaminates or residues in animal feed, according to the appearance of 
various cases of eggs, milk, or animal products. Compounds like hormones, 
antibiotics, dioxins, etc. have been found in feed either deliberately, from 
malpracticeor sloppy manufacturing practice. Particular attention should be paid 
on highly lipophilic compounds such as mycotoxins. The toxins can accumulate 
in organisms in which the transfer factor depends on the lipophilicity of the 
compound, the potential accumulation of the compound in animal matrices, 
and/or the feeding level and feeding period.The highest transfer factor 
determined in the order to fat>edible offal>meat>eggs>whole milk [LEEMAN et 
al., 2007]. 
A major factor of hazard potential to health and performance in livestock is the 
influence of the quality of the feed which is significantly affected by microbial 
contamination, thereby causing feed spoilage including mycotoxins. Therefore 
best conditions of all factors should be warranted, especially husbandry, feeding 
and disease prevention[HÖRÜGEL et al., 2003]. 
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In 1996, massive contamination of maize and cereal with Fusarium fungi has 
been determined in different parts of middle Europe [HÖRÜGEL et al., 2003]. 
Between 2004 and 2006 zearalenone was detected around 90% in 
unprocessed maize kernels samples. Over 200 µg/kg of zearalenone 
concentration could be determined in 25% of the samples. Guideline value for 
feed is 100 µg/kgand so only 50% of the unprocessed maize kernels could be 
used [ÖHLINGER 2008].However, ochratoxin A were found very rarely in 
Austrian cereals (median <0,0002 mg/kg) [ÖHLINGER et al., 2004]. 
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2.1.7 Livestock exposure 
 
2.1.7.1 Effects on Livestock 
 
To perceive the effects of mycotoxins in feed given to swine are not easy 
because typical diseases are not often triggered. Monogastric animals like pig 
or chicken are more vulnerable than ruminants due to the inactivation of 
mycotoxins in the rumen. Furthermore cases of loss are often caused by 
multitoxin attacks with unspecific health and performance depression. Feeding 
experiments show decreasing littering rates after giving Fusarium toxin 
contaminated dried feed over the whole pregnancy to sows. Significantly lower 
weight of the piglets and less vitality of the newborns were proven. Moreover 
the used feed is often not available anymore and retrospective investigations of 
mycotoxin content cannot be carried out.Experiments with 2000 sows that got 
fusariumtoxin contaminated feed after a strong Fusarium infestation on the field 
in this year, led to fertility- and litter rates by young and older sows. It was 
slowly improved after given unsuspicious feed from a new harvest of the 
following year [HÖRÜGEL et al., 2003]. 
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2.1.7.2 Effects of Zearalenone on animals 
 
Zearalenone can cause severe infertility and reproductive problems in animals 
[HÖRÜGEL et al., 2003].The structure of Zearalenone is similar to estrogens 
(see Fig. 11). The mycotoxin can act like estrogens because they can adopt a 
conformation which sufficiently resembles 17β-estradiol and other natural 
estrogens able to bind to the estrogen receptor [KRSKA and JOSEPHS 2001]. 
 
Source: http://www.revmedvet.com/2001/RMV152_219_234.pdf 
Fig.11Structures of Zearalenone and Estrone 
 
To affirm the fact that feed from the silo could also contain mycotoxins, it has 
been shown that green maize with high fusariumtoxin concentration after 
harvest, was still containing the toxin after some month.The silo feed was given 
to porker and approximately after four weeks female animals show typical 
hyperestrogen syndromes, particularly swollen vulva (see Fig.12) and mating 
behavior, which continued until the slaughtering over several months. The uteri 
of the slaughtered animals were significantly bigger and edematised. 
Additionally, high concentrations of zearalenone and derivates could be 
detected in the bile[HÖRÜGEL et al., 2003]. 
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Source: http://www.apsnet.org/edcenter/intropp/topics/Mycotoxins/Pages/Zearalenone.aspx,  
Date: 06.12.2010 
Fig.12Zearalenone may cause vulvovaginitis in young pigs 
 
2.1.7.3 Further toxin effects of mycotoxins for domestic animals 
 
In the following table the reproductive dysfunction due to zearalenone in pigs 
can be seen as reported by Gaumy et al. [GAUMY et al., 2001]. 
premature gilts 1 – 5 ppm vulva swelling, vulvovaginitis, 
nipple enlargement 
mature non pregnant 
females 
6 – 9 ppm Anestrus and maintained corpora 
lutea, Infertility, pseudo-pregnancy 
 20 ppm Ovarian and mammary anomalies 
Pregnant primiparous >30 ppm Inhibition of fetal development, 
embryonic mortality 
Reproductive sows >30 ppm Infertility, return into oestrus, 
pseudo-pregnancy 
Premature males 30- 40 ppm Delayed puberty, depression of 
spermatogenesis and libido 
Boars 200 ppm No anomaly 
Source: GAUMY et al., 2001 
Tab. 4Reproductive dysfunction due to zearalenone in pigs 
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2.1.7.4 Effects of Ochratoxin A on animals 
 
Ochratoxin producingfungal species occur worldwide.It is a contaminant of 
agricultural commodities, especially in cereals, but can also affect a variety of 
other food commodities.Contamination is often a result of poor storage or poor 
agricultural practice during drying procedures.The toxicological profile of 
ochratoxin A includes teratogenesis, nephrotoxicity and immunotoxicity and 
causes mycotoxicoses in animals, particularly in swine [KOTOWSKI et al. 
1993]. It is also rated as being carcinogenic in animals and the International 
Agency for Research on Cancer classified these toxins as a possible human 
carcinogen (group 2B) [WALKER 2002].The high affinity of ochratoxin A to 
proteins, especially to serum albumin, allows its transport in the organs of 
animals [HAGELBERG et al. 1989] In fact, animal products and tissues for 
human consumption may present ochratoxin A residues, even if the animal has 
been nourished with low contaminated feed. In many studies, ochratoxin A has 
been detected in different parts from pigs, such as blood, kidney, liver muscle 
and adipose tissue [MILICEVIC et al., 2008].Ochratoxin A was reported as a 
strong nephrotoxin for all kinds of mammals. ALowest Observed Effect Level of 
ochratoxin A about 8 µg/kg body weight per day could be derived from short 
term feeding studies in pigs [JECFA 2001]. At these levels, changes in nephritic 
specific enzymes and changes in elimination functions of the kidney occurred 
[ELLING 1979]. 
 
2.1.7.5 Effects of mycotoxins to the immune system in animals 
 
Mycotoxins can have different effects on the immune system, like inflammation, 
humoral immune response and cellular immune response. These effects on 
animal health could be increasing vulnerabilityfor infections. Reactivation of 
sub-clinical infections, decreasing vaccine efficacy and decreasing drug efficacy 
can be further consequences. 
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In a study form Stoev et al., experimental trails have been done to show that 
ochratoxicosis can have increasing effects on bacterial infection in pigs [STOEV 
et al., 2000]. 
Type of bacterial infection Control OTA 
1 ppm 
OTA 
3 ppm 
Salmonella cholerasuis 
(day 13) 
0/6 2/6 6/6 
Serpulina hyodissenteria 
and campylobacter coli 
(day 47) 
0/6 - 2/6 
Source: STOEV et al., 2000 
Tab. 5Ochratoxicosis effects of bacterial infection in pigs 
 
2.1.7.6 Mycotoxin effects on animal organs 
 
In a study from Milicevic D. et al. the occurrence of ochratoxin A and porcine 
nephropathy in Serbia was investigated. 90 samples of blood, kidney and liver 
were randomly selected from slaughtered pigs and analyzed for ochratoxin A by 
HPLC with FLD and MS/MS detection. 26.6% of the liver samples contained 
ochratoxin A in the range of 0.22-14.5 ng/g, the serum samples showed 
maximum concentration of 220.8 ng/ml and 52.5 ng/g in kidney samples were 
found. 
As the pictures below (Fig.13) demonstrate, histopathological examination of 
kidney confirmed tubulopathies with edema and cell vacuolization. In addition, 
hemorrhages and necrosis of proximal kidney tubules cells were found 
[MILICEVIC et al., 2008]. 
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Source: MILICEVIC et al., 2008 
Fig.13Dystrophy and vacuolar degeneration in the epithelium of proximal tubules’ cells (A), focal interstitial 
fibrosis (B), necrosis of proximal tubules’ cells (C) and hemorrhages in cortex (D) 
 
A recent study from Stoev S.on the carcinogenic and toxic effects of ochratoxin 
A in chicks show adenocarcinoma in the liver of male chicken after feeding 5 
ppm ochratoxin A via feed. The chicken died after the end of the 10 months 
experiment and also showed large grey white neoplastic foci in the liver which 
protruded significantly above its surface (see Fig. 14) [STOEV 2010]. 
 
Source: STOEV 2010 
Fig.14Adenocarcinoma in the liver of male chicken 
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2.1.7.7 Mycotoxin effects on animal blood 
 
A study form EasternEurope, estimated the occurrence of ochratoxin A in 
animal feed and metabolite residues in porcine blood serum in Poland. 40 and 
45 samples of feed and porcine blood serum were analyzed for ochratoxin A 
andin 25% of the samples ochratoxin A was present in both types of 
investigated material.Metabolites were found in 27.5% of the blood samples and 
7.5% of the feed samples. Furthermore, both sample matrices showed higher 
contamination in the winter season than in the spring season, maybe 
corresponding that kernels being stored afterexposed to spring thaw.Moreover 
increasing temperatures resulting in higher air humidity and as a consequence, 
in higher moisture content in stored cereals and feeds [KOTOWSKI et al., 
2000]. 
2.1.7.8 Mycotoxin effects on animal muscle compartment 
 
An Austrian study from Zöllner P. et al. reported that in all muscle tissue 
samples from pigs, zeranol was detected with concentrations of up to 13.3 
µg/kg along with α-zearalenol and traces of zearalenone and taleranol, with LC-
MS/MS detection.A possible explanation for this might be the fact that muscle 
tissue form the back is better supplied with blood, which can be considered as 
the most important transport system for the analytes in the animal body 
[ZÖLLNER et al., 2002]. 
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2.1.8 Human exposure 
2.1.8.1 Health Risk 
 
Mycotoxins are a diverse group of chemical compounds. If the levels in the diet 
are high enough, it can cause acute and/or chronic adverse health effects in 
humans. Mycotoxins can affect organs and systems in the body, notably the 
liver, the kidney, the nervous, endocrine and immune systems [KUIPER-
GOODMAN 1999]. Although secondary metabolites from fungi can never be 
completely removed from the food supply, risk analysis based on scientific 
knowledge makes it possible to define the levels in food (tolerances, guideline 
levels and maximum residue levels) that are unlikely to be harmful to health. 
In the table below you can see how Kuiper-Goodmann interpreted the health 
risk from contaminants in food: 
 
Source: KUIPER-GOODMAN, 1999 
Tab. 6 Rating health risks from foods 
The lack of harmonization among countries resulted in a wide variety of 
guidelines and regulations regarding mycotoxins. A leading role to approach 
risk analysis for all the compounds that may cause concern for food safetylike 
mycotoxins, had several international organizations such as WHO and FAO 
(especially through the Codex Alimentarius Commission, the Joint Expert 
Committee on Food Additives (JECFA), the International Agricultural Research 
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Centers, the Organization for Economic Co-operation and Development 
(OECD) and the International Life Science Institute (ILSI) as well as several 
national agencies. Therefore scientific evaluations became the basis for 
recommendations regarded by the Codex Committee on Food Additives and 
Contaminants and the European Union, in terms of international regulation for 
mycotoxins such as aflatoxins, ochratoxins, patulin and zearalenone. According 
to Kuiper-Goodmann “Risk is defined as the estimated likelihood of an adverse 
health effect, weighed for its severity, occurring in humans as a result of 
exposure to a biosocial, chemical or physical agent in food. A risk assessment 
involves a complete toxicological assessment, an epidemiological assessment, 
an exposure assessment and a risk characterization.”[KUIPER-GOODMAN 
1999] 
 
Source: KUIPER-GOODMAN 1999 
Fig.15Risk analysis framework for food safety 
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2.1.8.2 Hazard characterization 
 
Kuiper-Goodman stated that: “Hazard characterization is the extrapolation 
phase of risk assessment. Its aim is to make a predictive characterization of the 
hazard to humans, based on animal studies under low exposure conditions. The 
endpoint of hazard characterization is the estimation of a “safe dose” such as a 
provisional tolerable daily intake.”[KUIPER-GOODMAN 1999]. 
If there is probably a threshold of knowledge in the relationship between cause 
and effect of the mechanism and mode of action of a substance a TDI should 
be determined.Common practice to estimate a TDI for humans is to divide the 
No Observed Adverse Effect Level by a safety factor of 100 when extrapolating 
from animals to humans. This includes a factor of 10 for interspecies varieties 
and another factor of 10 for intraspecies differences.Furthermore it is important 
to take account to the exposure variety according to age, for instance that 
young childrenbeing exposed at a much higher rate in terms of body weight. 
Sometimes exposure assessment can be based on measurements of 
biomarkers in humans, for example for ochratoxins. Then the intake can be 
estimated on the basis of pharmacokinetic relationships[KUIPER-GOODMAN 
1999]. 
 
2.1.8.3 Risk characterization 
 
The severity and expected occurrence or absence of substance and 
theknowledge of the potential adverse health effects on an exposed population 
characterizes the risk and should be estimated qualitative and/or quantitative, 
including collateral uncertainties. Risk characterizations can for example being 
established for daily levels of exposure at which the risk is significant over a 
lifetime [KUIPER-GOODMAN 1999]. 
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2.1.8.4 Risk assessments 
 
For risk assessment evaluations have to be reexamined time by time. New 
information on both exposure and basic toxicology should be taken into account 
as well as improved understanding of mechanisms of action in the body. 
Detailed risk assessments have been done only for a few mycotoxins such as 
aflatoxins, deoxynivalenol, ochratoxin A, zearalenone and fumonisins [KUIPER-
GOODMAN 1999]. 
Thuvander et al. stated: “Even for the most well documented toxins, the 
tolerable daily intakes established by international working groups remain 
temporary or provisional due to insufficient toxicological information. A second 
problem in assessing the possible health risks due to exposure to mycotoxin is 
the lack of information on exposure” [THUVANDER et al., 2001]. 
 
2.1.8.5 Human exposure – Zearalenone 
 
Food safety authoritiesand scientistsall over Europe investigate the hazard of 
mycotoxin in their countries. Demonstrating that zearalenone are found all over 
the food chain a lot of surveys have been done.To describe the contamination 
in field crops Placinta et al. reported levels from few µg/kg up to 8 mg/kg of 
zearalenonein wheat, barley, oat, rye and feedsamples from Bulgaria, 
Germany, Finland, Netherlands, Norway and Poland [PLACINTA et al., 1999].In 
former Yugoslavia, zearalenone was found at high levels up to 10 mg/kg in 
maize [BALZER et al., 1977].Surveys from Hungary showed contamination of 
moldy and stored maize with zearalenone from 0.01 to 11.8 mg/kg. [FAZEKAS 
et al., 1996].Contamination of 14% of maize samples with a levels from 0.2 
mg/kg to 6.5 mg/kg was reported from Italy [SCOOP 2003].In the United 
Kingdom, zearalenone was detected in maize and ingredients of 
feed[SCUDAMORE et al., 1998] and in Scotlandhigh contamination of 
zearalenone in stored barley was detected at levels between 2.1 and 26.5 
mg/kg. [GROSS and ROBB 1975].Concerning on human exposure with 
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mycotoxins in Europe4918 cereal samples were analyzed for zearalenone.The 
occurrence of the toxin was reported in 32% of the samples in nine European 
countries. The distribution demonstrates that much of this contamination was in 
maize and wheat. Therefore raw maize was the nourishment with the highest 
level of zearalenone[ZINEDINE et al., 2007]. 
Zearalenone is found all over European crops which also reaches animals and 
humans after they consume these contaminated corps. In the following chapter 
results from animal testing is used to show the effects of zearalenone on 
animals.Furthermore, the impact of the toxin on humansisreported. 
 
2.1.8.5.1 Toxicity of zearalenone 
 
Fusarium species have been the reason for several human outbreaks of 
mycotoxicoses [HUSSEIN and BRASEL 2001]. Both deoxynivalenol and 
zearalenone have been linked to moldy grain toxicoses in the USA, China, 
Japan, and Australia, including symptoms such as nausea, vomiting, and 
diarrhea [BILGRAMI and CHOUDHARY 1998].In respect to acute toxicity, LD 
50 values from zearalenone are about 2.000-20.000 mg/kg b.w. A relative low 
acute toxicity was reported after several trails of oral administration in mice, rats 
and guinea pigs [FLANNIGEN 1991]. Subacute and subchronic toxicity 
identified a NOEL in pigs of about 40 µg/kg body weight/daycompared to NOEL 
indentified by Kuiper-Goodman et al. and JECFA of 100 µg/kg b.w. in 
rats.Moreover it should be mentioned that the International Agency for 
Research on Cancer classified zearalenone and its derivatives in group 3 [IARC 
1999] [ZINEDINE A. et al. 2007]. 
 
In a survey from Videmann B. et al. the metabolism and transfer of mycotoxin 
zearalenone was investigated in human intestinal Caco-2 cells using them as a 
model of intestinal epithelial barrier. As a result after given 10 to 200 µM 
zearalenone the survey shows on the one hand that the cell apical exposure to 
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zearalenone and α-zearalenol was predominantly found at the basal side. On 
the other handwere β-zearalenol and both glucuronides metabolitesespecially 
excreted at the apical side.Due to the fact that the strongest estrogenic activity 
results from α-zearalenol, the preferential production and the transfer of this 
metabolite to the basal side indicate that intestinal cells may contribute to the 
adverse health effects of zearalenone [VIDEMANN B. et al., 2008]. 
 
2.1.8.5.2 Zearalenone exposure in humans 
 
A surveys with 49 women of zearalenone in endometrial tissue show 27 
endometrial adenocarcinomas, 11 endometria hyperplasis and 11 normal 
proliferative endometrial. Zearalenone concentration of 47.8±6.5, 167.0±17.7 
ng/ml and below the limit of detection were found. Zearalenone was not 
detected in 8 cases of hyperplastic and 5 cases of neoplastic endometrial tissue 
[TOMASZEWSKI et al., 1998].From the southeast region of Hungary, 
zearalenone concentrations were found from 18.9 to 103.5 µg/ml in serum 
samples. Early telearche has been reported from the patients and zearalenone 
was also present in samples of food collected from the patients [SZUETZ et al., 
1997]. Nevertheless zearalenone can be found in every kind of nourishment 
and a potential danger of health could only be reached after absorption of high 
amounts or by exposure over a long period [ZINEDINE et al., 2007]  
 
2.1.8.5.3 Tolerable Daily Intake of zearalenone 
 
The Scientific Committee on Food has accepted a provisional TDI of 0.2 µg/kg 
body weight for zearalenone. 
[http://europa.eu/legislation_summaries/consumers/product_labelling_and_pack
aging/l21101a_en.htm]   
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2.1.8.6 Human exposure – Ochratoxin A 
 
2.1.8.6.1 Ochratoxin A exposure in food 
 
Plenty of ochratoxin Acontaminated food is found in Europe. 68.6% of 2374 
food samples were examined containingochratoxin A above the limit of 
detectionof 0.01 µg/kg [WOLFF 2000]. A large database, over 20,000 data 
points, of ochratoxin A levels exists. Subdivided into seven food categories 
(cereal and cereal products, wine, beer, grape juice, brewed coffee, cocoa and 
cocoa products, pork which contribute most to the ochratoxin A exposure 
[JECFA 2001],[EFSA 2005]. 
A special problem presents ochratoxin A in meat and meat products, as 
ochratoxincarry over from feed to meat has been experimentally established 
[MADSEN et al., 1982].Highly contaminated are the kidney followed by liver, 
muscle and fat. Noticeable amount of ochratoxin A have been found in blood. 
The occurrence of ochratoxin A in blood sausage from swine being 77.2%, 
livertype sausage (67.9%) and raw sausages (46.7%)[MORTENSEN et al., 
1983]. Maximum ochratoxin A levels of 4.6 and 3.2 µg/kg in blood and liver type 
sausages could be determined [PETZINGER and WEIDENBACH 2002]. 
The AGES reported ochratoxin A concentrations from a trial on 870 groceries 
samples. For examples in 257 samples of cereals and cereal products an 
average content of 0.26 µg/kg ochratoxin A was detected. In 131 meat samples 
the average value was below 0.1 µg/kg. Referring to this average daily intakes 
in Austria were between 0.09 – 0.16 µg. For high consumers the values 
increased up to 0.3 – 0.8 µg/day [RAUSCHER-GABERNIG and GROSSGUT 
2007]. 
Anaverage contamination of 0.11 µg/kg in 76 pork samples was found 
[JØRGENSEN 1998], while another survey showed an average ochratoxin A 
contamination of 0.14 µg/kg in 58 pork samples [GAREIS and SCHEUER 
2000]. 
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A dietary exposure assessment by EFSA 2006,indicates that average adult 
consumers (60kg) have an ochratoxin intake of 15 to 20 ng/kg b.w. per 
week.High consumers (97.5th percentile) have about 40 to 60 ng ochratoxin 
A/kg b.w. per week [EFSA 2006]. 
Frying or boiling could decrease the content of ochratoxin A in meat, but 
ripening processes have been proved to be ineffective for ochratoxin A 
reduction in meat products[TOSCANI T. et al., 2007]. 
 
2.1.8.6.2 Ochratoxin A exposure in humans 
 
South America studies reported the occurrence of ochratoxin A in human 
plasma, because of relatively low control by food safety authorities as well as 
bad manufacturing practice on the field and in storage facilities. A survey from 
Munoz K. et al. analyzed 88 blood samples from healthy donors from two 
different Chilean agricultural zones. 91% of samples from San Vicente de 
Tagua-Tagua and 54 % of samples from Colbún were positive to ochratoxin A. 
Detected levels were between 0.07 – 2.75 µg/kg and 2.12 µg/kg [MUNOZ et al., 
2006]. In another report from South America199 plasma samples, from blood 
donors in Mar del Plata and 236 from General Rodríguez, Argentina, were 
analyzed.63.8% of human plasma from Mar del Plata and 62.3% from General 
Rodríguez were positive for Ochratoxin A. Values could be determined between 
0.15 and 0.43 ng/ml [PACIN et al., 2008]. 
A relation in between dietary intake and the presence of ochratoxin A in human 
milk was explored by a study from Skaug M.A. et al. wherehuman milk samples 
were collected from 80 Norwegian women.A quantitative food frequency 
questionnaire was used to record the usual food intake during the last year. 
From the 80 human milk samples 17 have been contaminated with ochratoxin A 
in the range of 10 to 182 ng/l. The women with a high dietary intake of liver 
paste, liverwurst,cakes, cookies, fruitcakes, chocolate cakes, etc. were more 
likely to have ochratoxin Acontaminated milk. Also the risk of ochratoxin 
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Acontamination increased by the intake of all kinds of juice. Moreover, the 
resultsnotify that breakfast cereals, processed meat productsas well as cheese 
could be important contributors to dietary ochratoxin A intake [SKAUG et al., 
2001]. Additional to that, the ochratoxin A concentration in foetal serum is 
reported to be twice the maternal one. This indicates an active transfer of the 
toxin across the placenta [ZIMMERLI and DICK1995]. 
On the other hand a Scandinavian survey from Sweden tried to estimate the 
intake of some mycotoxins from food, in which 600 samples were collected and 
analyzed for ochratoxin A among other mycotoxins. Intakes were calculated for 
average and high consumers in adults and children and compared with the 
tolerable daily intake of 5 ng/kg body weight. They state that the exposure to 
mycotoxin in Sweden did not give rise to any major health concerns in the 
present, due to the fact that the intake of ochratoxin A was below the temporary 
TDI values from international expert groups[THUVANDER et al., 2001]. 
An average daily intake of ochratoxin A was calculatedon the basis of blood 
plasma concentrations to be 0.35ng/kg b.w./dayin Norway and 2.34 ng/kg 
b.w./dayin Spain. For babies daily ochratoxin A intake via breast milk is ranged 
from 1.0 ng/kg b.w./day in Norwayto 24.0 µg/kg b.w./day  in Italy 
[DUNKELBERG et al. 2007]. 
 
2.1.8.6.3 Toxicity of Ochratoxin A 
 
Information about the effect of ochratoxin A after a single exposition is limited to 
one case report from a farmer couple. After working (screen, sift) in a granary 
for eight hours the women got acute kidney failure with tubular necrosis. The 
wheat contained an Aspergillus species that produced ochratoxin A.A study 
from Germany investigated 6476 groceries and 927 serum samples from 
healthy donorsbetween 1995 to 1998. 98% of the blood samples dedicated 
positive, between 0.11 and 0.5 ng/ml. Comparable results reported from 
between 1977-1994 within the EU (0.45 ng/ml) and from a recent study from 
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several EU member countries (0.35 ng/ml). Even in breast milk ochratoxin A 
could be detected at a level of 0.18 µg/L[DUNKELBERG H. et al., 2007]. 
A lot of surveys have been done to investigate the correlation between 
ochratoxin A contamination in food and feed and the probability to cause Balkan 
Endemic Nephropathy [CASTEGNARO et al., 1987]. Balkan Endemic 
Nephropathy is a chronically progression renal tubulointerstitial disease. This 
disease appears in north-western Bulgaria, south-eastern Romania, and the 
former Yugoslavia (Serbia, Croatia, Bosnia and Herzegovina, Slovenia, and the 
Former Yugoslav Republic of Macedonia). Compared with other studies 
individuals with Balkan Endemic Nephropathy have higher ochratoxin A 
concentrations in blood and urine as healthy ones. In this study from Abouzied 
M.M. et al. they investigated ochratoxin A contamination in 165 samples of 
homeproduced food and feed from households in villages from the Balkan 
Endemic Nephropathy region of north-western Bulgaria.Households were 
Balkan Endemic Nephropathy occurs had more ochratoxin Apositive samples 
then the other households.Average per capita monthly consumption of basic 
food in rural Bulgaria, showed the highest ochratoxin A intake in Balkan 
Endemic Nephropathy households of 1.21 µg/day.In conclusion it is reported 
that the results indicate that ochratoxin A may not alone cause Balkan Endemic 
Nephropathy, but only synergistically with other environmental toxicants and/or 
predisposing genotypes [ABOUZIED et al., 2002]. 
In human ochratoxin Ashow unusual toxicokinetics. The toxin has a half life in 
blood of 840 h after oral ingestion.This long time of excretion of ochratoxin A in 
human can relate to the reabsorption during an enterohepatic circulation as well 
as extensive protein binding[SCHLATTER et al., 1996]. The elimination of 
ochratoxin A in the liver is maintained by protein carriers. The toxin is shuffled 
from its proteinbound form in blood into the hepatocyte. There it is secreted into 
bile. A further carrier system is involved in the uptake of ochratoxin A by 
proximal tubule cells, which secret the toxin into urine [TSUDA et al., 1999]. 
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2.1.8.6.4 Ochratoxin A effects on the immune system 
 
Toxic effects in the immune system resulting from very low concentrations of 
ochratoxin A in the ng/ml range, which is by far the most sensitive among all 
other sensitive organs.Ochratoxin A is an immunosuppressive agent[MÜLLER 
et al., 1999] and a concentration of 5 ng ochratoxin A per kg b.w. suppresses 
the immune responses in mice[HAUBECK et al., 1981].On one hand concerning 
the cellular immunity ochratoxin A inhibits the immune responses transmitted by 
B- and T-lymphocytes and on the other hand in question of the humoral 
immunity ochratoxin A induces a regression of IgGs, IgAs, and IgMs 
[PETZINGER E. and WEIDENBACH A. 2002]. 
2.1.8.6.5 Tolerable Daily Intake of Ochratoxin A 
 
In the year 2001 the WHO set a provisional tolerable weekly intake of 100 ng 
ochratoxin A/kg b.w. per week. The intake quantity relies on the NOAELfor 
nephrotoxic effects of ochratoxin A in male rats with a safety factor of 1500. 
Inside the EU daily intake differ in different countries due to varying food pattern 
and different ochratoxin A contamination of food from 0.53 in Great Britain to 
2.31 ng/kg b.w./day in France. The WHO established a PTWIof 100 ng/kg b.w. 
per week[DUNKELBERG H. et al. 2007]. 
The following table shows LD50 values of ochratoxin A (mg/kg body weight) for 
the mouse, rat, dog, pig and chicken. 
Species Oral i.p. i.v. 
Mouse 46 – 58.3 22 – 40.1 25.7 – 33.8 
Rat 20 – 30.3 12.6 12.7 
Rat neonate 3.9   
Dog 0.2   
Pig 1   
Chicken 3.3   
Source: Based on literature compilations in Harwig  et al., (1983) and NIOSH (1986) 
Tab. 7:  LD50 (mg/kg b.w.) values for ochratoxin A in various species  
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3 Materials and Methods 
 
3.1 Sampling 
 
The sample pool consists of 44 samples from main grocery stores in Austria, 
traditional butchers and discounters. Excluded were farmer markets, 
gastronomy, catering, suppliers on the “road” like gas station shops, airplane 
and train food down to school buffets and fast food suppliers. To include all of 
the distributers would go beyond the scope of this work and could be interesting 
for further studies.  
The idea behind the sampling was first of all to monitor the general 
concentration of mycotoxins coming through the food chain. The literature part 
above provides information from numerous studies on mycotoxin concentrations 
in animal body compartments. Less information is available about the 
concentration of the mycotoxins in processed products from pig. As a matter of 
fact pigs are very sensible organisms to mycotoxins and are one of the main 
sources for processed meat products in Austria. Furthermore the interest in 
mycotoxin-accumulation in different parts of the pig, which are separately used 
for different kinds of processed meat products, could also give indication of 
vulnerable organs in humans, exposed to mycotoxinsfrom contaminated food. 
The tissue distribution follows the pattern kidney>liver>muscle>fat [GALTIER P 
et al., 1981]. So as these parts are the main target for mycotoxin accumulation, 
the sampling focused on processed meat products containing these tissues. As 
a matter of fact kidneys are not often used in processed products.So more 
focus was put on mycotoxin research in the blood of swine, because former 
studies claim that in central European ochratoxin A is probably the most 
ubiquitous carcinogenic mycotoxin, which can be detected at levels higher than 
0.1 µg/kg in more than 90% of human and swine blood samples [RICHARD et 
al., 1999]. Additionally, the concentration of mycotoxins in blood led to the idea 
that the steady circulation of mycotoxins in blood plasma across the organism 
can have effects on blood compartments and further metabolic influences 
[PETZINGER E. and WEIDENBACH A. 2002]. 
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The table below shows the different products from various distributers 
containing the selected body parts (liver, muscle, blood and fat). 
 
Liver Muscle Blood Fat 
Chef Menu 
Leberspätzle 
Natur Pur Bio 
Knacker 
Blutwurst 
Trünkel 
Speck Bauer 
Chef MenuMini 
Leberknödel 
TANN Extra Blutwurst 
Schreiber 
Speck Mader 
Leberstreichwurst 
Stastnik 
Reiter Mettwurst Blutwurst 
Mader 
Speck Trünkel 
Leberstreichwurst 
Landhof 
TANN Fränkfurter Blutwurst 
Bauer 
LOIDL 
Haussalami 
Leberstreichwurst 
Jauntaler Billa 
Feinkost 
HAM 
Frühstücksfleisch 
  
Pluma Feine 
Leberpate 
TANN 
Pressschinken 
  
Inzersdorfer 
Leberaufstrich 
Iglo Fleischknödel 
(frozen) 
  
HAM Leberbrot    
Pate Grand Mere  
Brüsseler Art 
   
Reiter Röstzwiebel 
Streichwurst 
   
Radatz 
Leberstreichwurst 
   
Trünkel Feine 
Leberpastete 
   
Ablinger Streichwurst    
Trünkel Gutsleber 
Streichwurst 
   
Clever Streichwurst    
Gourmet 
Sahnestreich 
   
Primana 
Leberbrotaufstrich 
   
Knorr 
Leberknödelsuppe 
(dried) 
   
MHW Leberwurst    
Knorr 
Leberknödelsuppe 
(can) 
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Jensen's Luxus Leber 
Pete 
   
Tann Leberknödel 
Feinkost 
   
TANN Streichwurst 
fein 
   
Lutz Leberwurst    
Dulano Röstzwiebel 
Leberwurst 
   
Natur Pur Bio 
Streichwurst 
   
Dorfgold 
Sahnestreich 
   
Twinner Leberwurst    
Iglo Leberknödel 
(frozen) 
   
 
 
Tab. 8Products from various distributers containing the different body parts (liver, muscle, blood and fat) 
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3.2 Methods – Theoreticalbackground 
 
3.2.1 Extraction 
3.2.1.1 Solid phase extraction 
 
Solid phase extraction columns were invented in the mid 1970s [THURMAN 
and MILLS 1998].In 1978, Waters promoted the Sep-Pak cartridges, 
asconvenient and dry packed silica based disposable columns [MCDONALD 
and BOUVIER 1995]. The versatility of the SPE allows it to be used for a large 
number of functions, such as an effective method of sample purification, or for 
compound isolation and removal of reagents [WACHOB 1991]. It is effective 
because it is a quick procedure for separation and can enriches the minor 
components of a sample. A great number of quantitative techniques (HPLC, 
GC, UV) use the benefit of the SPE as a first step for analyzing methods [RUIZ-
GUTIERREZ and PEREZ-CAMINO 2000]. 
 
 
Source: 
http://www.waters.com/webassets/cms/category/media/other_images/primer_d_%20solidphase.jpg 
 
Fig.16 Principle - Solid Phase Extraction 
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SPE based on the principle of liquid chromatography.In these columns, strong 
but reversible interactions between the analyte and the stationary phase occur. 
Typical interactions arenonpolar interactions between the C-H links of the 
analyte and the C-H links of the absorbent so called Van der Waals forces. The 
most common support for non-polar interactions is C18 
cartridges.Nevertheless,C2 and C8 columns are also used for lipid separations. 
Polar interactions create links by hydrogen bonding (dipole-dipole forces, 
etc.).These interactions are typical of all the cyano (CN), amino (NH2), diol or 
silica (Si) supports. Furthermore, ion-exchange interaction occurs in a phase 
such as the one with quaternary amines, benzenesulfonic acids or 
propylsulfonic acids and take placewhen the analytes have negative or positive 
ionic charges [MCDONALD and BOUVIER 1995] [RUIZ-GUTIERREZ and 
PEREZ-CAMINO 2000]. 
 
3.2.1.2 Immunoaffinity chromatography 
 
Immunoaffinity purification is a highly specific andreversible technique, used for 
the one-step isolation of an analyte from many complex matrices and simplifies 
sample analysis relative to traditional clean-up techniques. The purification 
effect is based on the specific identification of a protein by an antibody or by 
enzymes using the specific affinity of an enzyme to inhibitors, substrate or co-
factors. The stationary phase is linked with a proper antibody, which is capable 
to specificallybind the analyte. Attention should be paid to the affinity of binding 
the analyte being not too high, because elution thereby can be more difficult. 
Application of an immunoaffinity column to isolate and concentrate an analyte 
decreases the amount of solvent used. Also decreases the number of 
purification steps and shortens analysis time. [SHELVER 2004]. 
For analyzes of Ochratoxin A respectively for the clean-up step, Ochraprep® 
immunoaffinity columns were used. The Ochraprep® procedure is based on 
monoclonalantibody technology. The column contains a gel suspension of 
monoclonal antibody specific for ochratoxin A, covalently attached to a solid 
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support. To remove unbound material the column can be washed 
withphosphate buffered saline. The bound toxin is released from the antibody 
following elution from the column with methanol:acetic acid (98:2 v/v) [R-
BIOPHARM RHÔNE LTD]. 
 
 
Source: http://services.leatherheadfood.com/mycotoxins/wp2training/immunoaffinity_principle.jpg 
Fig.17Principle – Immunoaffinity Columns 
 
3.2.2 High Pressure Liquid Chromatography 
 
The theory behind chromatography is the separation of two sample components 
based on their different distribution between two non-miscible phases. The one, 
the stationary phase, a liquid or solid, is fixed in the system. The other, mobile 
phase, a fluid, is streaming through the chromatographic system. This is the 
principle of chromatographic separation: Different distribution of the analytes 
between mobile and stationary phase results in different migration velocities 
[KENNDLER 2004]. 
High Pressure Liquid Chromatography is a separation process, where samples 
are flushed over a stationary phase with the help of eluent (liquid phase) under 
high pressure. Main characteristics are: [BERGER 1991] 
 Particles of the stationary phase are very small (1-10 µm diameter) which 
implicate a high active surface and so a huge separating capacity. 
 Column inner diameter is 2 – 4 mm 
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 There must be pressure to put the mobile phase through the column 
Schematic representation of High Pressure Liquid Chromatography:  
 
Source: Veronika Meyer, 4th edition, John Wiley and Sons, 2004, ISBN 0470093781, p. 7. 
andchromatography-online.org. Used file:Computer n screen.svg (Crystal SVG icons). (Date 15.1.2009) 
http://en.wikipedia.org/wiki/File:HPLC_apparatus.svg 
Fig.18Practical High-performance Liquid Chromatography 
(1) Solvent reservoirs, (2) Solvent degasser, (3) Gradient valve, (4) Mixing vessel for delivery of the mobile 
phase, (5) High-pressure pump, (6) Switching valve in "inject position", (6') Switching valve in "load 
position", (7) Sample injection loop, (8) Pre-column, (9) Analytical column, (10) Detector (i.e. IR, UV), (11) 
Data acquisition, (12) Waste or fraction collector. 
 
The sample solution is injected without pressure, in general over a sample loop.  
Most of the HPLC instruments have an autosampler to automatize the injections 
and it can be programmed over computer software. The solvents in the solvent 
reservoirs can be degassed in an ultrasonic bath. The gradient valve mixes the 
solvents in appropriate ratio. The HPLC procedure works here with two different 
methods: 
 isocratic: composition and flow are constant over the whole separation 
process 
 gradient elution: eluent composition and/or flow modified time dependent 
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Over the switching valve the solvents are added with the sample and 
transferred on the column where the separation takes place. Routinely a 
precolumn is used to protect the column from impurity.  
For the different liquid chromatographic separation problems variously filling 
materials for the column are available. The method used here was reversed 
phase chromatography. A non-polar stationary phase (octylsilica, 
octadecylsilica (C-18), hydrophobic polymere (polystyrol, divinylbenzol, 
polyacrylate)) and polar mobile phase (main component: water up to dioxane; 
modifier: methanol, ethanol, acetonitrile, tetrahydrofuran). 
 
At the end of the column the separated compounds are eluted. This is called 
retention time and it is the time at which a specific analyte elutes; the retention 
time under particular conditions is considered a reasonably unique identifying 
characteristic of a given analyte.  
Then the analytes are transferred to a detector like UV/Vis-, IR-, Fluorescence 
detector or Mass spectrometer. The output of the results is given in form of a 
chromatogram, where you can see the amount and the retention time of the 
analyte. 
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3.2.3 Detectors 
 
3.2.3.1 Fluorescence detector 
 
Fluorescence detector using a beam of light, usually ultraviolet light, that excites 
the electrons in molecules of certain compounds and causes them to emit light 
of a lower energy which intensity can be measured. Various light sources may 
be used as excitation sources, including lasers, photodiodes, and lamps; xenon 
arcs and mercury-vapour lamps in particular (wave length 200 – 800 nm). Limit 
of detection is in the ppb range. High selectivity due to the fact that only 
compounds can be detected that can be excited by fluorescence or which are 
modified to fluorescent derivates. 
 
3.2.3.2 Mass spectrometry 
 
Mass spectrometry is an analytic technique that measures charged particles in 
the mass-to-charge ratio. The principle comprehends of ionizing chemical 
compounds to generate charged molecules of molecule fragments and 
measurement of their mass-to-charge ratio [SPARKMAN 2000]. Samples are 
transferred to the mass spectrometer instrument and undergo vaporization. 
Components of the sample are ionized by for example impacting them with an 
electron beam. This results in the formation of charged particles so called ions. 
The ions are separated according to their mass-to-charge ratio, appearing in an 
electromagnetic field (analyzer). Quantitative methods are used to detect the 
ions and the signalsare converted into mass spectra. 
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3.2.3.2.1 Mass analyzer 
 
The ions produced in the ion source are getting accelerated over electric 
collimator into the analyzer. A negative potential at the blend accelerates 
positive charged ions (positive ion mode) and vice versa for negative charged 
ions (negative ion mode).The analyzer arranges the accelerated ions according 
to their mass-to-charge ratio (m/z). The velocity of the ions depends on charge, 
mass and acceleration voltage. The ions are spacial or temporal divided before 
they get to the detector. After appropriate calibration it is possible to determine 
exactly the mass-to charge ratio. 
 
𝑒𝑈 =  
𝑚𝑣2
2
 e: ionic (electric) charge [Coulomb, C]; 1 e0=1.60 x 10
-27 kg 
  m: mass in atomic mass unit (u); 1u = 1/12 of carbon-12 atom 
  1u is exactly 1.66 x 10-27kg  
 
𝑉 =  
2𝑒𝑈
𝑚
   v: velocity [m s-1] 
    U: acceleration voltage [V] 
 
There are many types of mass analyzers, using either static or dynamic fields, 
or magnetic or electric fields. There is also the possibility to use two or more 
mass analyzers for tandem mass spectrometry (MS/MS or MSn). 
 
Quadrupole mass filter: Quadrupole acts as a mass-selective filter. The 
quadrupole field is created by four parallel rods where a direct current voltage is 
overlaid by a high frequency alternating voltage. Only ions with certain m/z ratio 
have stable (oscillatory) trajectory in the quadruple field, all the other ones touch 
 55 
 
the field and discharge itself. Which m/z ratio runs on stable trajectories and hit 
the detector depends on the applied current voltage [U] and the amplitude of the 
alternating voltage [V]. A triple quad instrument is a combination of two 
quadrupole mass filters (tandem mass spectrometry), which are detached 
through collision cell. As a first step a precursor ion with a specific m/z ration is 
selected (Q1-cell). Next the Q2-cell is filled with nitrogen or argon and there the 
collision induced dissociation appears. The occurred fragment, called product 
ion, are sorted towards m/z ration in Q3-cell and finally scanned by a detector 
[HOPFGARTNER 2007]. 
 
3.2.3.2.2 Detectors 
 
At the end of the mass spectrometer is the detector. The ions pass by or hit on 
the surface and either the charge or the current is detected. Common types of 
use are photomultiplier, electron multiplier and faraday cups. The amount of 
ions leaving the analyzer is small, so amplification is often necessary to get a 
signal. 
 
3.2.4 Ion source: 
 
Atmospheric Pressure Chemical Ionization:After chromatographic separation 
the effluent enters the atmospheric pressure chamber, transported through a 
specially designed nebulizer needle. (See Fig. 19)The vaporizer is heating up to 
temperature of 400° C or 350° C when introducing a drying gas of nitrogen. This 
enhancesthe evaporation of the solvent. The corona needle is kept at high 
potential, resulting in a corona current. This supports ionization of the 
introduced molecules by help of solvent molecules. The molecular and cluster 
ions are deflected and enter the first vacuum stage through a metal plated 
fused-silica capillary. The role of this capillary is first to create a molecular leak 
between the API chamber and the first vacuum stage. Then initiate declustering 
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and partial fragmentation in the collision-induced dissociation region.This is the 
region between the end of the transfer capillary and the first skimmer. Here a 
voltage in the range of typically 10 to 100 V is applied. The ions are focused 
through an octapole mass filer, increasing the transmission of ions, when enter 
the high vacuum of the mass analyzer through a second skimmer 
[ROSENBERG et al., 1998]. 
 
 
Source: http://www.bris.ac.uk/nerclsmsf/techniques/hplcms.html 
Fig.19A schematic of the components of an APCI source 
 
 
Source: http://www.bris.ac.uk/nerclsmsf/techniques/hplcms.html 
 
Fig.20A more detailed view of the mechanism of APCI  
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3.3 Materials 
 
3.3.1 Chemicals and Solvents of Ochratoxin A analysis 
 
Chemicals: 
Water deionised, Acetonitrile, Methanol, Phosphate buffer tablets for PBS-
buffer, Acetic acid 100% (glacial acetic acid), Sodium hydrogen carbonate, 
Tween 20, Diethylene glycol 
Gas: 
Nitrogen 5.0, Helium 4.6 
Reference standard: 
Ochratoxin A, 50µg/ml in Benzene/glacial acetic acid (99/1), Ampul 1 ml 
Solutions: 
Stock solution of Ochratoxin A (2mg/l):1ml of Ochratoxin A Standard (50µg/ml) 
pipettes to 25 ml volumetric flask and evaporate under nitrogen flow at room 
temperature. Dissolve Ochratoxin A with methanol and fill up to the mark. 
External Standard 1 (200µg/l):1 ml of Stock solution pipettes to 10 ml volumetric 
flask and fill up with methanol to the mark. 
External Standard 2 (20µg/l):1 ml of external standard 1 pipettes to 10 ml 
volumetric flask and fill up with methanol to the mark. 
External Standard 3 (5µg/l):125 µl of external standard 1 pipettes into 5 ml 
volumetric flask and evaporate under nitrogen flow at 35°C. Dissolve ochratoxin 
A in reconstitution solution and fill up to the mark. 
Extracting agent:710 ml methanol and 290 ml water deionised 
Phosphate buffer solution (0.01M, pH 7.4):5 phosphate buffer tablets dissolve in 
1000 ml volumetric flask with water deionised and fill up with water to the mark. 
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Reconstitution solution:25 ml methanol, 75 ml water deionised and 1 ml glacial 
acetic acid 
Mobile phase:149.8g acetonitrile, 204g water deionised and 4 ml glacial acetic 
acid and degas in ultrasonic bath. 
Diethylene glycol solution (10%):1 ml diethylene glycol pipette into 10 ml 
volumetric flask and fill up with methanol to the mark. 
Tween 20-Solution (50%):5 ml Tween 20 pipette into 10 ml volumetric flask and 
fill up with water deionised to the mark. 
Equipment: 
Scale, Homogenizer, Ultraturax, Glass funnel, Pleated filter, Vac Elut 
workstation (ICT AI 600), Immunoaffinity column (Ochrapep®, Rhone-
Diagnostics), Plastic syringe, Ultrasonic bath, Volumetric flasks different sizes 
Laboratory glassware, Centrifuge tube with screw plug and Teflon seal, Sample 
vials (brown glass) (Chromacol 2CV (A)), Crimp Caps (Hewlett Packard), Seal 
pliers for sample vials, Piston stroke pipette, Disposable pipette tip 
Instruments: 
HP 1090 Liquid Chromatograph with fluorescence detector 1100 series and 
analytical workstation (Hewlett Packard) 
Column: ODS Hypersil, 5µm, 200mm x 2.1mm (Hewlett Packard) 
Precolumn: ODS Hypersil, 5µm, 20mm x 2.1mm (Hewlett Packard) 
Frit: 0.5µm premium steel frit 
 
3.3.2 Chemicals and Solvents of Zearalenone analysis 
 
The following information for chemicals and solvents of zearalenone analysis is 
based on the method of MARKER 2009. 
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Chemicals: 
Methanol HPLC Grade, Glacial acetic acid, Sodium acetate, Tert-butyl methyl 
ether, Acetate buffer (2 mol/l; pH 5.2), n-hexane, beta-glucuronidase-sulfatase, 
acetone, sodium hydroxide, HPLC water  
Gas: 
Nitrogen 5.0, Helium 5.0 
Solutions: 
Reference standards: α-zearalanol (zeranol), β-zearalanol, α-zearalenol, β-
zearalenol, zearalanon and zearalenon (Sigma), internal standard β-zearalenol-
d4 
Stock solution of α-zearalanol, β-zearalanol, α-zearalenol, β-zearalenol, 
zearalanon and zearalenon (1000 µg/ml) in methanol 
Methanol stock solution of beta-zearalenol-d4 (100 µg/ml) 
Standard working solution (10 µg/ml):100 µl of all six methanol stock solution 
(α-zearalanol, β-zearalanol, α-zearalenol, β-zearalenol, zearalanon and 
zearalenon (1000 µg/ml)) pipette to 10 ml volumetric flask and fill up with 
methanol to the mark. 
Internal Standard (1 µg/ml):100 µl of methanol stock solution of beta-zearalenol-
d4 (100 µg/ml) pipette to 10 ml volumetric flask and fill up with methanol to the 
mark. 
Spiking solution (0.1 µg/ml) of stock solution of α-zearalanol, β-zearalanol, α-
zearalenol, β-zearalenol, zearalanon and zearalenon and β-zearalenol-d4. 
Calibration solution (0 – 50 ng/ml):Spiking solution and methanol-water-solution 
(v/v%-50/50) 
Storage for all solvents at 4°C under light protection. 
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Concentration of internal standard in all standard solutions amounts 50 ng/ml, 
corresponding 2.0 µg/kg Liver. 
Acetate buffer (2 mol/l; pH 5.2):Dissolve 25.2g acetic acid and 129.5g Sodium 
acetate in 800 ml water. pHadjusts with acetic acid or sodium acetate to 5.2 and 
fill up with water deionised to 1000 ml. 
Eluent for SPE:Methanol/water (80/20 v/v-%), Acetone/methanol (80/20 v/v-%), 
Methanol/water (50/50 v/v-%), Methanol/water (40/60 v/v-%) as wash solution 
HPLC mobile phase A: methanol, HPLC mobile phase B: water deionised 
Equipment: 
SPE columns C18, SPE columns NH2, 50 ml plastic tubes, 15 ml glass tubes, 
Glass-HPLC-vials with 100 µl glass vial inserts with polymer feet, Blue screw 
caps, PTFE with red silicon septa 
Instruments: 
HPLC Agilent Technologies 1200 series 
Applied Biosystems 4000 Q-Trap LC/MS-MS 
Column: ODS Hypersil 5µm, 200 mm x 2.1 mm 
Precolumn: ODS Hypersil 5µm, 10 mm x 2.1 mm 
 
  
 61 
 
3.4 Methods 
3.4.1 Sample preparation 
 
The sample preparation occurred in the preparation section of the competence 
centre of Veterinary Drugs and Hormones. There, samples were homogenised 
with a small electrical appliance (Moulinette), packed in resealable plastic 
packaging, labelled and stored at -18° C. 
3.4.2 Sample extraction method 
 
For zearalenone the existing method was validated only for liver matrix and so 
further experiments with other matrices (e.g. liver dumpling, bacon, sausage, 
blood sausage) had to be realized, because of the possibility of matrix 
depended interaction of compounds (see below 3.4.4 Validation). 
3.4.2.1 Extraction method- Ochratoxin A 
 
Weigh in 15 g homogenized sample (+/- 0.1g accurately) into a 300 ml 
volumetric flask. Add 100 ml extracting agent and 1.35 g sodium hydrogen 
carbonate. Homogenize all for 3 min with ultraturax and filter with pleated filter. 
Immunoaffinity column clean up:Fill in 5 ml from the eluate with 1 ml Tween 20 
solution and 65 ml phosphate buffered saline, merge and fill into plastic 
reservoirs of the immunoaffinity columns. Apply the sample with a flow rate of 1 
drop/s (max. 3 ml/min) to the column. Afterwards wash with 10 ml deionised 
water and then remove the plastic reservoir. 
Elution of immunoaffinity column: Apply a 20 ml centrifuge tube into the Vac 
Elut workstation. Elute with 4 ml methanol without vacuum. Press the rest of the 
remaining methanol through the IAC with the help of a plastic syringe, add 100 
µl diethylene glycol to the eluate and dry it at 40°C while adding nitrogen gas. 
Solve it in 1 ml reconstitution solution. 
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As the distribution of mycotoxins is generally non-homogeneous, samples 
should be prepared, and especially homogenised, with extreme care. 
For the analyzing of mycotoxins, daylight should be excluded as much as 
possible during the procedure, since some mycotoxins gradually break down 
under the influence of ultra-violet light[COMMISSION REGULATION No 
401/2006]. 
 
3.4.2.2 Extraction method – Zearalenone 
 
The following method is based on the studies of Marker C.[MARKER 2009]. 
Weigh 5 g (+/- 0.01 g) sample into 50 ml plastic tube. 
To determine the recovery rate, the current retention time and the ion ratio 
control sample must be applied. A negative sample is added with 100 µl 
standard solution(0.1 µg/ml) which is equivalent to 2 µg/kg Liver. 
To all sample and control samples 100 µl of the internal standard solution (0.1 
µg/ml) is added, which is also equal to 2 µg/kg Liver. 
Add 40 µl beta-glucuronidase-sulfatase and 2 ml acetate buffer (2 mol/l; pH 5.2) 
for deconjugation. Shake it on the Vortex. Control the pH with 1 M acetic acid or 
0.1 M sodium hydroxide at pH 5.2. Hereafter the samples are incubated over 
night by 37°C in a water bath. 
On the next day the samples are taken out of the bath and cooled down to room 
temperature. Thereafter 10 ml tert-Butyl methyl ether (TBME) is added and 10 
min. shaken. Then centrifuged at 4000 rpm for 5 minutes.The upper organic 
(TBME) phase is transferred into 15 ml glass tubule with screw caps and the 
TBME is vaporized at 50°C under nitrogen flow. The residue is solved in 5 ml 
methanol/water (v/v-% 50/50) by shaking 30 sec on the vortex. 
Next step is the defattening step. 1 ml n-hexane is added, 30 sec rotation on the 
vortex and centrifuged at 4000 rpm for 5 minutes. Subsequently the upper 
phase is sucked off. Repeat this step. 
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For the solid phase extraction with SPE C18, the samples are first added with 2 
ml deionised water because of the polarity effectsand besides the SPE columns 
are preconditioned with first 5 ml methanol and then 5 ml deionised water. The 
sample extract is applied on the column, observing that the columns do not run 
dry. Afterwards the washing step follows. 5 ml methanol/water put through the 
columns and finally the columns are dried with the help of a vacuum. 
The elution occurs with 5 ml methanol/water (80/20 v/v-%) also with a vacuum 
(not under 820 mbar) in 15 ml glass tubule with screw cap. The eluate is dried 
under nitrogen flow at 50°C. 
The dried eluate is dissolved in 5 ml acetone/methanol (80/20 v/v-%) by rotating 
30 seconds on the vortex. 
For the solid phase extraction with SPE NH2 columns the tubules are 
preconditioned with 5 ml acetone/methanol (80/20 v/v-%). The sample is 
applied on the column and the eluate is caught in 15 ml glass tubule. The eluate 
is dried again with the help of nitrogen flow at 50°C and afterwards dissolved in 
0.5 methanol, shaken for 30 seconds on the vortex, and again vaporized. At the 
end the residue is solved in 200 µl methanol/water (50/50 v/v-%), shaken on the 
vortex and filled up in 2 ml glass-HPLC-vials with cartridge. 
 
3.4.3 Analyzing 
 
For analyzing of zearalenone and its metabolites the method of MARKER 2009 
was used. 
Differences in varying fat amount of the samples, especially high fat 
concentration in liver paste samples, had the consequence that it was not 
possible to evaporate to dryness after extracting with TBME. 
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3.4.3.1 Ochratoxin A – Analysis 
 
Column: ODS Hypersil, 5 µm, 200 mm x 2.1 mm 
Precolumn: ODS Hypersil, 5 µm, 20 mm x 2.1 mm 
Frit: 0.5 µm premium steel frit 
Mobile phase: 149.8g acetonitrile, 204g water deionised, 4ml 
glacial acetic acid 
Flow: 0.2 ml/min 
Temperature: 35°C 
Injection volume: 250 µl 
Fluorescence 
detection: 
 
Wavelength excitation: 333 nm 
Wavelength emission: 460 nm 
Tab. 9 Parameters for Ochratoxin A determination 
 
3.4.3.2 Zearalenone – Analysis 
 
Column: ODS Hypersil, 5 µm, 200 mm x 2.1 mm 
Precolumn: ODS Hypersil, 5 µm, 20 mm x 2.1 mm 
Mobile phase: A: methanol; B: water deionised, degassed 
Gradient: 0 min: 50% A, 50% B 
20 min: 100% A, 0% B 
21 min: 50% A, 50% B 
31 min: 50% A, 50% B 
Injection volume: 25 µl 
Flow: 0.25 ml 
Temperature: 250°C 
Tab. 10Parameters for the determination of zearalenone by LC-MS/MS-method 
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Parameters for the MS/MS-method in APCI negative mode: 
Substance Precursor Ion Product ion I Product ion II 
Zearalanon 319.1 275.0 106.7 
Zearalenon 317.1 131.1 174.8 
alpha-zearalanol 321.0 276.6 62.9 
beta-zearalanol 321.0 276.6 62.9 
alpha-zearalenol 319.1 275.0 129.8 
beta-zearalenol 319.1 275.0 129.8 
Beta-zearalenol-d4 
(internal standard) 
323.2 159.7  
Tab. 11MS/MS-parameters of zearalenone and its metabolites determination with LC-MS/MS 
 
Below an extracted ion chromatogram of zearalenone and metabolites 
(standard solutions) determined with APCI-MS/MS, 4000qtrap, in negative 
mode. 
 
Fig.21Chromatogram standards zearalenone and metabolites, APCI MS/MS, 4000qtrap, negative mode  
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3.4.4 Validation 
 
The Validation was implemented to determine the Level of quantification (LOQ) 
and the Level of detection (LOD). In the following it is explained which 
parameters have to be calculated for confirmation methods according to CD 
2002/657/EC. The confirmation criteria are explained for the analysis of 
zearalenone and its metabolites. 
The analysis is based on the method from [MARKER 2009], which was 
validated by CD 2002/657/EG. The method was validated for liver and urine. To 
confirm the received values from this survey, an appropriate validation has to be 
implemented due to the fact that the sample pool mostly consists of liver-
matrices. 
The table below show LOD (CCα), CCβ, LOQ for zearalenone and metabolites 
in liver samples from Marker 2009: 
Substances LOD (CCα) 
(µg/kg) 
CCβ (µg/kg) LOQ (µg/kg) 
α-zearalanol 0.38 0.60 0.76 
α-zearalenol 0.59 0.93 0.95 
β-zearalanol 0.34 0.55 0.78 
β-zearalenol 0.31 0.49 0.56 
zearalanon 0.44 0.69 0.88 
zearalenon 0.47 0.75 0.90 
Source: Based on MARKER 2009 
Tab. 12 relative CCα, CCβ values and LOQ of zearalenone and its metabolites in liver samples 
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To get the parameters in accordance with conventional methods it is needed to 
perform several individual experiments. For multi-analyte methods, several 
analytes can be analyzed simultaneously, as long as possibly relevant 
interferences are ruled out. 
With the help of the absolute recovery rate it is possible to monitor the amount 
of the analyte that left through the extraction process. The method validated for 
liver samples (Marker 2009) showed following recovery rates: 
 
Substance Recovery rate 
(absolute) 
Recovery rate (related 
to internal standard) 
α-zearalanol 12.6% 100.7% 
β-zearalanol 13.2% 105.9% 
α-zearalenol 17.1% 121.6% 
β-zearalenol 11.8% 88.1% 
zearalanon 20.0% 154.1% 
zearalenon 13.4% 96.5% 
Source: Based on MARKER 2009 
Tab. 13 Summary of average values of recovery rates of zearalenone and its metabolites in liver samples 
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3.4.4.1 Definitions 
 
Decisional limit CCαand detection capability CCβ: By definition of the Official 
Journal of the European Union from the 17.08.2002: “Decision limit (CCα) 
means the limit at and above which it can be concluded with an error probability 
of α that a sample is non-compliant.”.“The CC𝛽 has been defined in the 
2002/657/EC as:“the smallest content of the substance that may be detected, 
identified and/or quantified in a sample with an error probability of 
𝛽.”[COMMISSION DECISION 2002/657/EC 2002]. 
Two methodologies for the determination of these critical concentrations (CC𝛼 
and CC𝛽) during method validation are defined by the Commission Decision 
2002/657/EC.The first method is based on the determination of signal to noise 
ratio of 3:1 in blank samples and matrix material fortified at the CC𝛼. The 
second method refers to the international standard ISO 11843-2, in which CC  
and CC  based on a linear regression model analyzing fortified material at 
different concentration levels. [VAN LOCO et al., 2007]. 
Limit of quantification: is the lowest concentration of an analyte that can be 
quantitative estimated with a defined precision. Only quantitative values can be 
specified that reaches that limit. It is assumed that the LOQ is according to a 
signal to noise ration of 10:1. 
Relative ion intensities:“The relative intensities of the diagnostic ions and/or 
precursor/product ion pairs have to be identified by comparing spectra or by 
integrating the signals of the single mass traces. Whenever background 
correction is applied, this shall be applied uniformly throughout the batch and 
shall be clearly indicated” stated by the Official Journal of the European 
Communities. (See Tab.14)[COMMISSION DECISION 2002/657/EC 2002]. 
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Relative ion intensity  
(% of base peak) 
Maximum permitted tolerance 
>50 % ± 20 % 
>20 % to 50 % ± 25 % 
>10 % to 20 % ± 30 % 
≤10 % ± 50 % 
Source: [COMMISSION DECISION 2002] 
Tab. 14Maximum permitted tolerance for relative ion intensities of mass spectrometric techniques. 
 
 
3.4.5 Performance characteristics 
3.4.5.1 Determination of CCα, CCβ and limit of quantification for zearalenone 
 
In the first pre-trial samples of blood sausage (blood), lard (fat), sausage 
(muscle), liver, liver dumplings, liver paste, pork blood, and bacon were tested 
at the experimental model: standard series of 0.08, 0.72, 1.36, 2.00, 4.00, 6.00, 
10.0µg/kg(methanol stock solution of alpha-zearalanol, beta-zearalanol, alpha-
zearalenol, beta-zearalenol, zearalanon and zearalenon (1000 µg/ml) and 
methanol stock solution of beta-zearalenol-d4 (100 µg/ml)) for calibration. Each 
sample was analyzed blank and spiked. Additional to that one blank liver 
sample was analyzed to compare the validated method from Marker C. 2009, 
and three spiked ones. This was accomplished to verify if this method is 
applicable to processed products from pig. Hereby it was well spotted that the 
employment of the method to this samples was possible. By the detection of the 
same amounts of internal standard in the liver samples and the other processed 
productsamples, it could be concluded that the method could be used for this 
task and further validation steps could be followed. 
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In the following assay steps the samples for the validation were settled to the 
groups of blood sausages, sausages, liver dumplings, liver paste and bacon for 
the different matrices blood, muscle, liver, and fat. 
According to this validation step each group (blood sausages, sausages, 
processed liver products and bacon)was spiked with ascendant concentrations 
of the standards (0.3, 0.6, 0.9, 1.2, 1.5, 1.8 µg/kg) to obtain a calibration curve. 
The results were evaluated by ISO11843 and DIN 32645. Therefore the 
“Response” of each concentration was used to determine the CCα, CCβ, the 
limit of detection and the limit of determination for each ion (precursor and 
product ion). The Limit of detection was affirmed by a significance level of 99% 
and 95% for the limit of quantification. 
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3.4.5.2 Zearalenone limit of detection and limit of quantification for all samples 
 
In the tables below all results from the validation approach for the limit of 
detection and the limit of quantification are reported. The values for the LOD are 
evaluated by DIN 32645 and ISO 11843 to the significance level of 99 %. The 
values for the LOQ are evaluated by DIN 32645 to the significance level of 95%. 
The value of the less sensitive ion is used for the detection limit and is declared 
in [µg/kg]. 
Blood sausage: 
 
Substance LOD (CCα) 
(µg/kg) 
CCβ 
(µg/kg) 
LOQ (µg/kg) 
a-zearalanol  0.53 0.69 1.11 
a-zearalenol  0.49 0.65 1.04 
b-zearalanol  0.48 0.63 1.01 
b-zearalenol  0.55 0.73 1.17 
zearalanon  0.60 0,79 1.27 
zearalenon  0,60 0,78 1.26 
Tab. 15Limit of detection (CCα), CCβ, Limit of quantification [µg/kg] for zearalenon in blood sausage 
 
 
Frankfurter (muscle) 
 
Substance LOD (CCα) 
(µg/kg) 
CCβ 
(µg/kg) 
LOQ (µg/kg) 
a-zearalanol  0.32 0.42 0.69 
a-zearalenol  0.36 0.48 0.77 
b-zearalanol  0.27 0.36 0.59 
b-zearalenol  0.31 0.41 0.67 
zearalanon  0.57 0.76 0.76 
zearalenon  0.35 0.46 0.75 
Tab. 16Limit of detection (CCα), CCβ, Limit of quantification [µg/kg] for zearalenon in frankfurter 
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Processed liver products: 
 
Substance LOD (CCα) 
(µg/kg) 
CCβ 
(µg/kg) 
LOQ (µg/kg) 
a-zearalanol  0.26 0.34 0.56 
a-zearalenol  0.44 0.58 0.66 
b-zearalanol  0.34 0.45 0.74 
b-zearalenol  0.21 0.28 0.48 
zearalanon  0.35 0.47 0.76 
zearalenon  0.20 0.27 0.46 
Tab. 17Limit of detection (CCα), CCβ, Limit of quantification [µg/kg] for zearalenon in liver dumpling 
 
Bacon (fat) 
 
Substance LOD (CCα) 
(µg/kg) 
CCβ 
(µg/kg) 
LOQ (µg/kg) 
a-zearalanol  0.37 0.48 0.79 
a-zearalenol  0.57 0.75 0.93 
b-zearalanol  0.31 0.41 0.67 
b-zearalenol  0.38 0.50 0.82 
zearalanon  0.49 0.65 1.04 
zearalenon  0.71 0.93 1.52 
Tab. 18Limit of detection (CCα), CCβ, Limit of quantification [µg/kg] for zearalenon in bacon 
 
 
 
3.4.5.3 Determination of the recovery rate 
 
Each of the 44 samples were analyzed twice, one blank sample and one spiked 
sample. Additional to that one blank liver sample and one spiked liver sample 
were investigated to confirm the recovery rates. For the evaluation of the 
received recovery rates the usage of the method from Marker C. could be 
confirmed again due to the fact that the results from the different matrices did 
not show any abundance. 
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The determination of the recovery rates follows the following calculation model: 
𝑅𝑒𝑐𝑜𝑣𝑒𝑟𝑦 𝑟𝑎𝑡𝑒  𝑠𝑝𝑖𝑘𝑒𝑑 𝑠𝑎𝑚𝑝𝑙𝑒 =  
𝑐𝑜𝑛𝑐. 𝑠𝑝𝑖𝑘𝑒𝑑 𝑚𝑒𝑎.
𝑐𝑜𝑛𝑐. 𝑒𝑥𝑝.
 ∙ 100 [%] 
Conc. spiked mea.: measured concentration of the spiked sample [µg/kg] 
Conc.exp.: expected concentration of the spiked sample 
(theoretical) [µg/kg] 
With the help of the recovery rate it is possible to monitor the loss of the amount 
of an analyte during the extraction process. 
For the quantification of the samples a correction of recovery rate, called 
relative recovery rate, referring to the internal standard is necessary. Therefore 
possible extraction differences can be adjusted, so that variations could be 
reduced.Internal standardβ-zearalenol-d4 was used. 
The variations in the recovery rates are resulting in slightly physical and 
chemical differences from zearalenone and its metabolites to the internal 
standardβ-zearalenol-d4. Reasons for this are matrix effects like matrix 
compounds that influence the ionization process or for example influences of 
background noise to peak integration. 
 
  α-
zearalanol 
α-
zearaleno
l 
β-
zearalano
l 
β-
zearaleno
l 
 
zearalano
n 
 
zearaleno
n 
Processed liver 
products(liver) 
121,1% 84,0% 138,5% 110,6% 62,1% 54,3% 
Sausages(muscl
e) 
131,5% 75,1% 147,2% 116,8% 86,8% 44,6% 
Blood 
sausages(blood) 
156,6% 92,7% 186,2% 116,2% 128,2% 44,3% 
Bacon (fat) 137,3% 85,4% 159,4% 113,2% 77,1% 47,0% 
 
Tab. 19Relative recovery rates of zearalenone determination (LC-MS/MS) for liver, muscle, blood, fat 
compartments 
Absolute recovery rates are showing the actual detected values and give 
information about losses that occur through the whole extraction process.  
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  α-
zearalanol 
α-
zearalenol 
β-
zearalanol 
β-
zearalenol 
 
zearalano
n 
 
zearaleno
n 
Processed liver 
products(liver) 
23,9% 15,1% 26,5% 20,8% 17,5% 8,1% 
Sausages(muscl
e) 
22,8% 13,7% 26,8% 21,4% 15,8% 7,5% 
Blood 
sausages(blood) 
17,7% 10,4% 17,2% 12,6% 15,7% 5,8% 
Bacon (fat) 10,4% 7,8% 13,6% 9,6% 6,6% 4,0% 
Tab. 20Absolute recovery rates referred to internal standard of zearalenone determination (LC-MS/MS) for liver, 
muscle, blood, fat compartments 
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3.4.5.4 Validationfor Ochratoxin A 
 
The samples of blood sausage, sausages, liver dumpling and liver paste were 
spiked with 0.5 µg/kgand 1.0 µg/kg and analyzed. (See table 21) 
 
 
Sample name spiked with 
Ochratoxin 
A[ng/kg] 
Ochratoxin A 
conc. from 
spiked samples 
[ng/kg] 
Recovery rate 
[%] 
Liver dumpling 1 0 0 0 
Liver dumpling 2 500 430 86 
Liver dumpling 3 1000 888 89 
Blood sausage 1 0 0 0 
Blood sausage2 500 433 87 
Blood sausage3 1000 1020 102 
Frankfurter 1 0 0 0 
Frankfurter  2 500 415 82 
Frankfurter  3 1000 993 99 
Liver Pâté 1 0 90 - 
Liver Pâté  2 500 502 (412) 82 
Liver Pâté  3 1000 959 (1049) 105 
Bacon 1 0 0 0 
Bacon 2 500 537 107 
Bacon 3 1000 982 98 
Tab. 21Validation experiment – Recovery rates for Ochratoxin A 
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To determine the LOD and the LOQ, a five point linear calibration line was 
made, at concentrations of 0.01 µg/l, 0.025 µg/l, 0.05 µg/l, 0.1 µg/l and 0.25 
µg/l. The values for the LOD are evaluated by DIN 32645 to the significance 
level of 99 %. The values for the LOQ are evaluated by DIN 32645 to the 
significance level of 95%. 
 
Substance LOD [µg/l] LOQ [µg/l] LOD [µg/kg] LOQ [µg/kg] 
Ochratoxin A 0.010 0.025 0.013 0.033 
 
The analyses of the contaminated samples were repeated to verify the results. 
Therefore each contaminated sample was investigated twice, one blank sample 
and one sample spiked with 0.133 µg/kg ochratoxin A (respectively 0.1 µg/l). 
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4 Results and Discussion 
 
4.1 Results 
4.1.1 Results – Zearalenone and metabolites 
 
From the 44 analyzed samples, two samples show resultsabove the limit of 
detection. 0.54 µg/kgα-zearalenol (LOD: 0.44 µg/kg; LOQ: 0.66 µg/kg),0.22 
µg/kg zearalenon (LOD: 0.20 µg/kg; LOQ: 0.46 µg/kg). One value was above 
the LOQ, 0.82 µg/kg β-zearalenol (LOD: 0.21 µg/kg; LOQ: 0.48 µg/kg) in a liver 
dumpling sample (Tann Leberknödel). Another liver dumpling sample (dry 
product and not ready to consume) contains 0.52 µg/kg zearalenon(LOD: 0.20 
µg/kg; LOQ: 0.46 µg/kg) (Knorr Leberknödelsuppe,dried). 
The following figure shows the chromatogram of zearalenone and its 
metabolites in a liver dumpling sample. It was determined with APCI-4000 qtrap 
in negative mode. 
 
Fig.22Chromatogram Liver dumpling – zearalenone and metabolites, APCI MS/MS, 4000qtrap, negative mode 
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Furthermore there is evidence that in another processed liver product sample 
zearalenon could be found close to the limit of detection (LOD: 0.20 µg/kg 
zearalenon). But concerning the validation of the limit of detection for liver 
dumplings, this value could not be specified at significance level of 99%. This is 
also true for a liver pâté sample concerning α-zearalenol (LOD: 0.44 µg/kg). 
A mean recovery rate of 121 – 137% (10 – 24%) for α-zearalanol, 75 – 92% (8 
– 15%) for α-zearalenone, 138 – 186% (13 – 27%) for β-zearalanol, 110 – 117 
% (10 – 21%) for β-zearalenol, 62 – 128% (6 – 17%) for zearalanon and 44 – 
54% (4 – 8%) for zearalenon. The results in the brackets are absolute values. 
Products with a high muscle percentage and also bacon samples did not show 
any concentration of zearalenone. 
 
4.1.2 Results – Ochratoxin A 
 
The 44 samples,same as from zearalenone analytical study, where determined 
also for ochratoxin A.  
From these samples 5 products with a main liver component show a significant 
concentration of ochratoxin A above the limit of quantification (LOQ: 33 
ng/kg)(see table 22). One sample show values above the limit of determination 
(LOD: 13 ng/kg) at the second analysis. 
 Processed 
liver products 
OTA conc. [ng/kg] OTA conc. [ng/kg] 
 124 86 
  155 107 
  73 47 
  201 131 
  34 > LOD 
Tab. 22Concentration [ng/kg] of Ochratoxin A in Liver dumpling- and Liver pâté samples 
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In two blood sausages samples values could be specified above the limit of 
quantification (LOQ: 33 ng/kg), although one sample show values above the 
limit of detection at the second analyzing step. 
 
Blood sausage OTA conc. [ng/kg] OTA conc. [ng/kg] 
 >LOD 42 
 93 96 
Tab. 23Concentration [ng/kg] of Ochratoxin A blood sausage samples 
 
The chromatogram below shows the determination of ochratoxin A (at 10.385 
min) in a liver paste sample with HPLC-FLD detection. 
 
Fig.23 Chromatorgramm of Ochratoxin A in a liver pâté sample. 
 
No significant concentrations are found in products that mainly consist of 
muscle meat and products with high amount of fat.  
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4.2 Discussion 
 
The main aim of this work was the determination of zearalenone, a mainly field 
mycotoxin, and its metabolites and the ubiquitous, mainly storage mycotoxin, 
ochratoxin A in processed products from pig to clarify the carryoverfrom field, 
over contaminated feed up to human nourishing medium.  
At this moment, neither a survey of the occurrence of zearalenone and its 
metabolites nor for ochratoxin A contamination in processed products of pig in 
Austria had been done.  
Several national and international studies on the effects of mycotoxins on 
human suggest different ways of dealing with the problem.Nutrition, being an 
interdisciplinary field of study, sees many factors playing together when 
mycotoxins occur in the food chain. Accurate analyzes of environmental toxins 
are requirement for science basedadvices. Governmental or non-governmental 
organizations have to handle estimated values and set guidelines. Nutrition and 
health are topicsthat are deeply involved in every day’s life and regulations 
therefore are influenced by a lot of stakeholders. Detected values of substances 
in nourishing mediums are only numbers and are meaningless when they do 
not fit into the right surrounding. The importance of highly developed analysis 
methods helps to focus where even very low concentrations of highly toxic 
compounds appear. Information of chemical analysis helps to determine where 
prevention strategies should or canbe implemented. Moreover some groups of 
persons are more sensitive to toxic substances and therefore special maximum 
permitted values should be evaluated. In future there should be more non 
nutrients diet surveys to estimate the usual intake of food chemicals like 
mycotoxins [COUNIL E. et al., 2006]. 
Germany, Switzerland and Sweden for example discuss limit values of 0.01 – 
0.03 µg/kg for ochratoxin A in infant food. Even though it was reported that only 
3 % of the Swiss population could exceed the proposed “virtually safe dose” of 
5 ng/kg b.w. per day, the exposure of the population to ochratoxin A should be 
low as reasonably achievable [ZIMMERLI B. and DICK R., 1995]. Moreover, the 
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distribution of mycotoxins into human milk was reported. The exposure to 
ochratoxin A during the foetal and neonatal period is may be potentially harmful 
[SKAUG M.A. et al., 2001]. 
Furthermore, it has been reported that in areas where Balkan Epidemic 
Nephropathy occurs ochratoxin A was found in human blood. Especially due to 
bad storage conditions of food at home mycotoxins can enter the human body. 
The survey from Balkan as well as from Argentina showed that lower socio-
economical levels correlated with higher ochratoxin A contamination in blood 
[PACIN A.M. et al., 2008]. 
Nevertheless referred to Grossgut, AGES, the average daily intake of 
zearalenone is about 0.2 µg/kg b. w. This is only a fragment of the currently 
allowed dose of 1 µg/kg b.w. per day in Austria. Investigated foods in Austria 
(by AGES) presented a certain contamination with ochratoxin A, which did not 
refer to a TWI (100 ng/kg body weight per week) by average consumption in 
any population group. For high consumers or e.g. preschooler the TWI could be 
reached. 95.5 % of the ochratoxin A concentration of food investigated in 
Austria lay below maximum values. Summarizing the health risk for the Austrian 
population from the intake of Ochratoxin A over food in the investigation 
timeframe from 2003 to 2007 seems to be low [RAUSCHER-GABERNIG E. and 
GROSSGUT R., 2007]. 
The following discussion show the analyzed values of zearalenone and 
metabolites as well as ochratoxin A values found in Austrian processed 
products from pig to identify hazards coming from this kind of nourishment. 
Furthermore the discussiondoes involve the advantages of novel analytical 
methods and further development of faster, less expensive and more accurate 
analysis. Moreover,nations are working together to deal with hazards like 
mycotoxins in the food chain and at no time before it was that easy to have 
international information exchange over the whole planet as nowadays. With the 
help of information technologies scientists as well stakeholders, NGO’s, 
governments etc. can handle problems faster and better prepared.  
 
 
82 
 
But it is important to understand the reasons for regulations and guidelines. This 
discussion contains a part of explanations why detection methods should be 
enhanced. This information should help to understand the occurrence of 
mycotoxins in human life much better and that it is a global problem affecting us 
permanently. 
Therefore prevention strategies for mycotoxin contamination are a major step. 
Both substances, zearalenone and ochratoxin A, show that the diversity of their 
appearance, through for example climate conditions or cultivation, is manifold. 
Prevention is a first step to avoid the carry over through all kinds of processes 
of food. For the future all groups of interests have to have a conscientiously look 
to the possibilities and hazards of new technologies in prevention. 
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4.2.1 Analysis of food samples 
 
44 products from pig, divided into four different compartments (liver, muscle, fat, 
and blood), were determined for zearalenone and metabolites as well as for 
ochratoxin A. 
The Results show that only two samples contain values between the LOD and 
LOQ of zearalenone. One of these samples contains β-zearalenol above the 
limit of quantification (0.82 µg/kg). In sausage and bacon samples no significant 
detection of zearalenone and metabolites could be established. 
The other liver dumpling sample from a dry product contains 0.52 µg/kg 
zearalenon (LOD: 0.20 µg/kg; LOQ: 0.46 µg/kg) (Knorr Leberknödelsuppe, 
dried). This product is going to be boiled with water. Therefore the amount of 
toxin will be much lower for consumption. 
Recovery rates, LOD and LOQ were similar to the method of Marker C. for liver 
samples. All results were corrected with the estimated relative recovery rates. 
Ochratoxin A could only be found in liver and blood samples, where 5 samples 
with main liver components showed significant concentrations. Values are 
between 34 and 201 ng/kg (LOD: 13ng/kg; LOQ: 33 ng/kg). In two samples with 
blood as main component, concentrations of ochratoxin A between 42 and 96 
ng/kg, could be determined. 
No significantconcentrations are found in products with main amount of muscle 
meat and products mostly consisting of fat.  
A lot of surveys reports contamination of crops with mycotoxins all over the 
world. Even though not every kind of mycotoxin is able to develop in Austria,a 
lot of different mycotoxins can reach into the food chain be trading crops from 
all over the world. Storage fungi produce mycotoxins like ochratoxin A and 
crops like maize could contain this toxin and travel around the globe. The usage 
of contaminated crops for feed is still common. To be frank it is impossible to 
achieve crops free from all environmental toxins, but that is not the point. 
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Millions of year’sspecies of all kinds interact among each other and many 
mechanisms in organisms are generated to handle hazards from the 
environment. But especially risk groups like infants, elderly or people who suffer 
from diseases should be reason for further lower guidelines in food. 
It refers to good manufacturing practices to produce high quality food. In the 
chapter below some prevention strategies will be discussed. For examplemaize 
harvests contain a few contaminated kernels and after milling the mycotoxins 
aredistributedall over the product. To handle such problems awareness training 
should be accessible for all participants through the food chain processes. 
From the literature is known that mycotoxins follow different matrices in body 
compartments. The results led to the conclusion that the distribution of 
mycotoxins in pigs correlates with the distribution pattern 
liver>blood>muscle>fat. No determined values from this study show any risk for 
human health, but the results indicate processed liver and blood products to be 
of more health concern than for example sausages with high meat content. 
Moreover the information of the distribution of mycotoxins from this and from 
former studies refer to consideration that liver and blood in human body are 
compartments that are more sensitive to mycotoxins. This led to the conclusion 
that more research can be done on this sector of risk factors.  
In the literature it was demonstratedthat values can be determined in human 
blood and human milk, also to point out that this are risk factors especially for 
infants and elderly as well as for patient who have problems with theirimmune 
system. New maximum intake levels will be discussed and also therefore 
enhanced detection methods described, which will be necessary for further 
investigations to very low concentration levels. 
The increasing costs for highly sensitive analyzing methods have to be justified. 
New methods therefore have been established and further are coming. The 
combination of different methods will help to adjust the right demands for 
analytical questions. Especially immunoaffinity based methods can enhance the 
quality of determination, but also novel strategies like multi-mycotoxin detection 
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methods or biotechnology methods will help to increase analytical costs and are 
less time consuming in the laboratories. 
 
4.2.2 Development of mycotoxin issues 
 
The advantage of the IAC to SPE columns was the decreased amount of 
solvent used. Due to the less purification steps it simplified the sample analysis 
and shortened the analysis time [SHELVER 2004].Even though mass 
spectrometry detection is the current reference method for mycotoxin 
determination, the high costs and the extensive workflow lead to the conclusion 
that immunochemical techniques remain the method of choice for screening 
large numbers of samples [ROSEN S. 2009]. 
In future mycotoxin detection will move from specialized laboratories to the point 
of service. New technologies emerge with miniaturization of chromatographic 
techniques such as laboratory-on-chips or by the replacement of antibodies by 
DNA aptamers. The goal is to provide instant results from like harvesting 
machinery or grain escalators where such methods can give immediate 
decisions. [KARLOVSKY P. 2009] 
Further novel strategies for mycotoxin detection are multi mycotoxin detection 
methods. In Austria only a few scientific groups are searching for an accurate 
method to combine the highly selective determination of the different kinds of 
mycotoxins. Worldwide first developed multi mycotoxin methods focused on 
Aspergillus, Penicillium, Alternaria or Fusarium toxins. Further published 
methods included mycotoxin metabolites, masked mycotoxins and ergot 
alkaloids. [MONBALIU S. et al., 2010] A first multi mycotoxin method that meet 
al AOAC Official Method acceptability criteria using multitoxin immunoaffinity 
column cleanup with liquid chromatography and fluorescence detection for 
determination of aflatoxins B1, B2, G1, G2 and ochratoxin A in powdered ginger 
[TRUCKSESS M. W. et al., 2008]. Further 23 mycotoxins (aflatoxin B1, B2, G1, 
G2, ochratoxin A, deoxynivalenol, zearalenone, fumonisin B1, B2, B3, T2-toxin- 
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HT2-toxin, nivalenol, 3-acetyldeoxynivalenol, 15-acetyldeoxynivalenol, 
diacetoxyscirpenol, fusarenon-X, neosolaniol, altenuene, alternariol, alternariol 
methyl ether, roquefortine-C, and sterigmatocystin) in feed could simultaneously 
detected by LC-MS/MS and validated according to Commission Decision 
2002/657/EC and accredited by EN ISO 17025 [MONBALIU S. et al., 2010]. 
For samples with a content lower than 0.5 µg/kg, interfering associated 
substances affect the analysis negative due to the fact that at a measuring 
range of 330/460 nm these substances have a native fluorescence. An 
improved specific analytic method for ochratoxin A, is combining HPLC 
separation with enhanced fluorescence detection by post-column addition of 
ammonia. The quantitation limit for ochratoxin A was improved and estimated at 
5 – 10pg/g for human milk and serum. Advantages of this method are for 
example that the excitation- and emission wave length shift in this range or that 
at 390/440 nm native fluorescence disturbs much lesser. The sensitivity of the 
method increases dramatically, because of the resulting derivate having a 
higher fluorescence intensity than pure ochratoxin A and associated interfering 
substances get “invisible” due to derivatization [KASTRUP S. and AULWURM 
U. 2002] 
For further perspective it should be mentioned that prevention strategies in 
agriculture for mycotoxin contamination are manifold. For example plowing 
could reduce the proliferation of Fusarium spp. over winter by forwarded 
degradation of infected material in deeper bottomset beds, especially at 
preceding crops with high hazard potential like wheat and maize. Furthermore 
infected kernels should be eliminated by cleaning procedures from the crops, 
e.g. for example remove dust, small particles, weed seeds, etc. Then separate 
lighter kernels from the rest, peel and moist crushing (milling) the crop. In the 
end the yield could be washed, before dried to low aw and stored. Over 50% of 
mycotoxins could be eliminated with these measures. Storage fungi demand 
lower demands than field fungi and therefore they can proliferate at inferior 
water content [COENEN 2003]. Although interaction between relative humidity, 
temperature in storage facilities and water content in crops are explored, the 
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daily practical implementation are not always used and followed. New storage 
technology for crops is cool storage around 10°C to sustain quality of the goods 
and minimize the growth of insect pests and mites. It is noticed that bugs and 
mites could create temperature increase in stored crops. 
If it is not possible to cultivate mycotoxin free crops, detoxification of the feed 
could be a method. These feeds with less mycotoxin content could be given to 
less sensitive livestock like fattened bull, poultry or hog. In some countries 
contaminated material could be diluted with non contaminated crops. But this 
method will not have a promising future because of food safety measures of 
health consumer protection. It should also be mentioned that chemical treated 
feed, e.g. urea, sodium-disulfide or sodium hydroxide solution can significantly 
lower the mycotoxin contamination but can only be given to cattle. Feed treated 
with mycotoxin binder or by enzymatic cleavage inactivation show no 
significantly effect in surveys [HÖRÜGEL K. et al., 2003]. 
Ochratoxin A is thermally stable and can remain stable over years. On the one 
hand reports mentioned that the toxin is not destroyed by heating, roasting or 
common food preparation procedures [EFSA 2006]. On the other hand some 
effects have been shown by extrusion cooking of hulled barley meal. 17 to 86 % 
of ochratoxin A was destroyed after the process by temperature level of 160° C 
and 24 to 30 % moisture content for 70 seconds. Further studies can be done to 
animal feed if after treatment with heat can lower mycotoxin concentrations 
[CASTELLS et al., 2006]. 
A lot of mills reject wheat deliveries, when they are suspicious of being 
contaminated with mycotoxins. They could be detected either by optical check 
(red kernels, see Fig. 24, 25) or ELISA tests in the incoming control. But it 
should also be noticed that often the values of contamination are overestimated 
due to improper sampling. Often the investigation of the contaminated crops 
should be determined on the field, where they are not rehashed for example by 
pre-cleaning. This can reduce the zearalenone contamination significantly due 
to the fact that the majority of the toxin is located in the dust of the cereals and 
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the external parts of the kernels. Marketable cleaning facilities in mills are able 
to reduce zearalenone contamination by 50% [BICKERT C. 2003]. 
 
 
Source: http://www.ces.ncsu.edu/depts/pp/notes/Corn/corn001.htm 
Fig.24The fungus Aspergillus flavus sporulating on corn. 
Fig.25Corn kernels infected with Fusarium moniliforme showing "starburst" symptom 
 
The high usage of fungicides is neither cost effective nor environmental 
acceptable and residuals on food is not wanted. For pre and post harvest 
processes effective methods to reduce or eliminate ochratoxin A contamination 
are needed. An alternative method could be natural products. Substances of 
piperaceous plants may be effective in reducing ochratoxin A contamination in 
agricultural commodities. It was noticed that four alkaloids from this plants had 
effects on ochratoxin A, B and citrinin producing Aspergilla and they were also 
toxic to grain storage insect. But also reported was the moderately toxicity to 
mice of piperine and piperlongumine [LEE S.E. et al., 2007]. 
Biotechnology methods will help to reduce mycotoxins in cereal grains. New 
information on fungal and plant genomes and gene expression was developed. 
Complete genomes of Fusarium graminearum and Fusarium verticillioides and 
several Fusarium gene expression sequence databases can help to identify 
mycotoxin biosynthetic and regulatory genes [DESJARDINS and PROCTOR 
2007]. But controversy discussion rose whether environmental safety, 
intellectual property rights, consumer choice, ethics, food security, poverty 
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reduction and environmental conservation can go along with this new 
technology. Lower levels of mycotoxins as well as reduced needs for 
herbicides, pesticides, water and tilling are extraordinary effects [KENDRA and 
DYER 2007]. A study from 2007 reported about a transgenic maize line that can 
mediate detoxification in kernels. For the elimination of zearalenone 
egfp::zhd101 gene (gfzhd101) was used, encoding a protein fused to a 
zearalenone degrading enzyme. Further studies will develop anti-mycotoxin 
antibodies or mycotoxin-degrading enzymes. Even if the transgenic strategies 
have not yet achieved a practical level of resistance to fungi on the field, 
Genetic Modified crops will be part of our future. Effects on nutritional properties 
and the risk form allergens have to be assessed in the future [IGAWA T. et al., 
2007]. 
From a critical point of view, to show how important it is to coordinate all kinds 
of transactions to regulate the mycotoxin problem and put efforts to the right 
place the statement of the former UN Secretary Kofi Annan has to be 
mentioned. He said that: “A World Bank study has calculated that the European 
Union regulation on aflatoxins costs Africa $750 million each year in exports of 
cereals, dried fruit and nuts. And what does it achieve? It may possibly safe the 
life of one citizen of the European Union every 2 years … Surely a more 
reasonable balance can be found.” [CARDWELL et al., 2001]. It is clear that by 
trade barriers global economical problem appear. The statement shows that 
food compounds like mycotoxins are reaching a wide field in human 
coexistence. 
In the end more personal responsibility must be transferred to the consumer 
and knowledge must be strengthened so that everyone can do his/her own part 
to prevent the intake of mycotoxins through the food chain. This must not 
implicate that everyone has to improve their scientific knowledge but a lot can 
be done to enhance common sense for daily life problems. Legislations already 
discuss to implement health lesson in school to enhance the awareness of the 
pupils to the environment. And further cooperation between agriculture and 
governments as well as food safety authorities should be extended.  
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5 Conclusion 
 
This study along with several other studies done before concludes that 
mycotoxins are still a problem on the field and in livestock breeding. The 
average intake of Austrian inhabitants of mycotoxins through the food chain 
however is not perilous. But as we know from animal and genetic studies 
zearalenone and metabolites as well as ochratoxin A are severe toxins to 
human exposure and should be kept as low as possible. Especially for risk 
groups like infants and the elderly, it is important to continue searching for more 
health risk information and appropriate tolerable intake values. Summarizingthe 
detected values from this study of zearalenone and metabolites as well as 
ochratoxin A were not of any health concerns to the Austrian population. 
Multi mycotoxin methods, similar to the one used in this study for zearalenone 
and its metabolites with APCI-HPLC-MS/MS, will help to optimize time and 
material consuming single methods for analyzing mycotoxins in food matrices. 
For further investigation, the usage of immunoaffinity methods can be applied to 
multi-mycotoxin determinations, for efficient removal of interfering substances. 
Mycotoxins can “travel” through the food chain and start in growing on the field, 
developing in storage facilities and accumulation in livestock organisms. To 
prevent agricultural loss and health risk factors, several prevention strategies 
are implemented. Soil cultivation, alternative fungicides and biotechnology as 
well as appropriate storage manufacturing practice, cleaning procedures and 
screening methods of crops can reduce mycotoxin contamination in the food 
chain. Even the awareness of feeding uncontaminated feed to livestock before 
slaughtering show significant reduction of mycotoxins in food. 
Through globalization,mycotoxin contamination is not only a homemade 
problem. Mycotoxins like ochratoxin A remain stable over years and trading with 
contaminated goods could lead to trading problems and economical losses. 
Due to enhanced determination methods, toxic substances can be found in 
every kind of nourishment. Furthermore due to less information from animal and 
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genetic studiesrisk assessment and regulation limits are often performed basing 
on worst case scenarios. For most of the contaminants, this will lead to an 
excessive overestimation of residue levels. Mycotoxin like ochratoxin A or 
zearalenoneare potential health risk factors and concentrations in the food 
chain should be kept as low as possible. Even for the most well documented 
toxins, the tolerable daily intake remains temporary or provisional due to 
insufficient toxicological information. A further problem to determinethe health 
risks of mycotoxin is the lack of information on exposure [THUVANDER et al., 
2001].Moreover,several secondary fungi metabolites and other environmental 
toxins are consumed and therefore combined toxicity is very complicated so 
that the exposure often results in an additive effect, indicating a synergistic 
interaction [MONBALIU S. et al., 2010]. The chronic effects are more severe 
than the acute toxicity of mycotoxins so that even with small amounts of the 
toxin, constant intake can influence human life right at the beginning by 
accumulation in blood and human milk. Risk assessment for high risk groups 
like fetus, babies, children, sick persons or elderly should be done and more 
information about occurrence should be coming from appropriate dietary 
surveys. These evaluations need to be reexamined from time to time taking into 
account new information on both exposure and basic toxicology as well as 
improved understanding of mechanism of action [KUIPER-GOODMAN 1999]. 
But also personal responsibility and enhanced knowledge on nutrition are very 
important factors to take care of each individual life. 
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Recommendations from EFSA 2006 for ochratoxin A prevention could be taken 
as a guideline for first steps for the next years to overcome the problem. These 
recommendations can also be used for other mycotoxins. 
 Continuing efforts to reduce ochratoxin A contamination in foods. 
(Monitoring programs targeted to known and emerging sources of 
exposure) 
 More data on relationship between maternal exposure and resulting 
human milk concentrations. 
 Adequate studies on reproductive and developmental toxicity are 
needed. 
 Need for data on species specific accumulation of ochratoxin A in the 
kidney. 
[EFSA 2006] 
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6 Summary: 
 
Mycotoxins are widespread contaminants of feedand food, meat, cheese, 
spices and beverages, coming from different kinds of fungi that grow on almost 
every kind of nourishment. Zearalenone and its metabolites are nonsteroidal 
estrogenic mycotoxins produced by Fusarium species, colonizing maize as a 
special problem in Austria. Ochratoxin A is mainly produced by the four genera 
of fungi Fusarium, Claviceps, Aspergillus and Penicillium.In human blood 
ochratoxin A has been reported in several studies and the main concerns are 
the carcinogenic, nephrotoxic potential and alterations of immune responses. 
The toxins are mainly transmitted to swine by contaminated feed from which 
carry-over to humans has been demonstrated. An HPLC-APCI-MS/MS method 
with SPE extraction for the determination of the mycotoxin zearalenone and its 
metabolites and an HPLC-FLD method with IAC extraction for ochratoxin A 
detection was used to clarify the mycotoxin content in processed products from 
pigs in Austria. Both methods were applied to 44 food samples of processed 
products from pigs with the main focus of containing liver, muscle, fat and blood 
amount where former studies show a mycotoxin accumulation in these parts of 
livestock.The concentrations of zearalenone and metabolite in most samples 
were too low for quantification. Two samples show results above the limit of 
detection. 0.54 µg/kg α-zearalenol (LOD: 0.44 µg/kg; LOQ: 0.66 µg/kg), 0.22 
µg/kg zearalenon (LOD: 0.20 µg/kg; LOQ: 0.46 µg/kg). One value was above 
the LOQ, 0.82 µg/kg β-zearalenol (LOD: 0.21 µg/kg; LOQ: 0.48 µg/kg) in a liver 
dumpling sample.  Another liver dumpling sample contains 0.52 µg/kg 
zearalenon (LOD: 0.20 µg/kg; LOQ: 0.46 µg/kg). This product was dried and 
concentration of the toxin in rehydrated food would be diluted.From the samples 
5 products with a main liver component show a significant concentration of 
ochratoxin A above the limit of quantification (LOQ: 33 ng/kg). In two samples 
with high blood amount, values could be specified above the limit of 
quantification (LOQ: 33 ng/kg). A maximum concentration of ochratoxin A was 
201 µg/kgfound in a Liver pâté sample. No significant concentrations of 
zearalenone and metabolites as well as ochratoxin A could be detected in 
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processed products from pig with a main ingredient of meat or fat. That refers to 
the distribution pattern liver>blood>muscle>fat of mycotoxins in higher 
organisms. 
The occurrence of zearalenone and metabolites as well as ochratoxin A in 
processed products from pig should not be a matter of serious concerns. 
Undertaken measures to prevent mycotoxin contamination in Austria are well 
developed and knowledge could be spread to other countries. Nevertheless, the 
exposure of the population with potential human toxins should be as low as 
reasonably achievable. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 95 
 
7 Zusammenfassung 
 
Mykotoxine sind weitverbreitete Kontaminanten in Futtermittel und Lebensmittel 
wie Fleisch, Käse, Gewürze, Früchte und Getränken und werden von 
verschieden Arten von Pilzen produziert. Zearalenon und seine Metaboliten 
gehören zu den nonsteroidalen östrogenen Mykotoxinen und werden von 
Fusariumspezies gebildet. Der Befall von Mais ist in Österreich ein spezielles 
Problem. Ochratoxin A wird hauptsächliche von vier Pilzarten produziert, 
Fusarium, Claviceps, Aspergillus und Penicillium. Das Vorkommen von 
Ochratoxin A im menschlichen Blut, die krebserregende und Nieren 
schädigende Wirkung, sowie Veränderungen im Immunsystem wurden in 
mehreren Studien aufgezeigt. Die Gifte sind hauptsächlich in Schweinen zu 
finden, die mit kontaminiertem Futtermittel gefüttert wurden. Eine Übertragung 
von Schweinefleisch auf den Menschen konnte gezeigt werden. Mittels einer 
HPLC-APCI-MS/MS Methode mit SPE Extraktion für Zearalenon und seinen 
Metaboliten und eine HPLC-FLD Methode mit IAC Extraktion für Ochratoxin A, 
wurde die Gehalte dieser Gifte in verarbeiteten Lebensmitteln vom Schwein aus 
Österreich bestimmt. 44 Lebensmittelproben aus verarbeiteten Lebensmitteln 
vom Schwein wurden untersucht. Unterschieden wurden die Proben im Anteil 
von Leber, Muskel, Fett und Blut, da diese Körperkompartimente in vorigen 
Studien Akkumulationen dieser Gifte zeigten. Die gefundenen Konzentrationen, 
von Zearalenon und Metaboliten waren in den meisten Proben unter der 
Bestimmungsgrenze. Zwei Proben zeigten Werte über der Nachweisgrenze. 
0.54 µg/kg α-Zearalenol (NG: 0.44 µg/kg; BG: 0.66 µg/kg) und 0.22 µg/kg 
Zearalenon (NG: 0.20 µg/kg; BG: 0.46 µg/kg). In einer Leberknödelprobe war 
der Wertfür β-Zearalenolmit einer Konzentration von 0.82 µg/kg (NG: 0.21 
µg/kg; BG: 0.48 µg/kg)über der Bestimmungsgrenze. In einer weiteren 
Leberknödelprobe konnte eine Konzentration von 0.52 µg/kg Zearalenon (NG: 
0.20 µg/kg; BG: 0.46 µg/kg) detektiert werden. Fünf der 44 Proben mit hohem 
Leberanteil und zwei Blutwurstproben zeigten signifikante Konzentrationen von 
Ochratoxin A über der Bestimmungsgrenze von 33 ng/kg. Die höchste Menge 
von 201 µg/kg Ochratoxin A konnte in einer Leberpastetenprobe analysiert 
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werden. Keine signifikanten Werte konnten in jenen Proben festgestellt werden, 
die hauptsächlich aus Muskel oder Fett bestanden. Diese Ergebnisse 
korrelieren auch mit dem Verteilungsmuster der Gifte in höheren Organismen 
(Leber>Blut>Muskel>Fett).Das Vorkommen von Zearalenon und seinen 
Metaboliten sowie Ochratoxin A in verarbeiteten Lebensmitteln vom Schwein 
geben keinen Grund für gesundheitliche Bedenken. Die unternommenen 
Maßnahmen zur Prävention in Österreich sind gut entwickelt und dieses Wissen 
kann an andere Länder weitergegeben werden. Dennoch sollte die Exposition 
mit potentiell giftigen Substanzen für den Menschen so niedrig wie möglich 
gehalten werden. 
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